Danksagung Fr die kritische und konstruktive Durchsicht des Manuskripts danken wir allen in der STIKO-Arbeitsgruppe Immundefizienz mitarbeitenden Expertinnen und Experten sowie Miriam Wiese-Posselt, Judith Koch und Sabine Vygen-Bonnet, fr die redaktionelle Durchsicht Eva Wetzel aus dem Fachgebiet Impfpr?vention am Robert Koch Institut. Ein besonderer Dank gilt auch Christof Schaefer vom Pharmakovigilanzzentrum Embryonaltoxikologie der Charit-Universit?tsmedizin Berlin fr die kritische Begutachtung und fachlicher Beratung im Abschnitt in utero-Exposition. Abkrzungen AIAuffrischimpfungAKAntik?rperALLAkute Lymphatische Leuk?mieAnti-HBsAntik?rper gegen Hepatitis?B-surface-AntigenASCO Typ?bHIVHumanes Immundefizienz-VirusHPVHumanes PapillomavirusHzHerpes zosterIDWPder EBMTIgImmunglobulineIgGImmunglobulin?GIPDengl. (frher WeltgesundheitsorganisationWPVWildpoliomyelitisvirus Interessenkonflikt H.-J.?Laws, U.?Baumann, C.?Bogdan, G.?Burchard, M.?Christopeit, J.?Hecht, U.?Heininger, I.?Hilgendorf, W.?Kern, K.?Kling, G.?Kobbe, W.?Klper, T.?Lehrnbecher, R.?Meisel, A.?Simon, A.?Ullmann, M.?de Wit und F.?Zepp geben an, dass kein Interessenkonflikt besteht. Literatur 1. Acar S, Gencdal G, Kirimlioglu H, Polat KY, Cagatay AA, Akyildiz M. Varicella-Zoster Virus-Induced Hepatitis in a Liver organ Transplant Receiver: AN INSTANCE Record. Transplant Proc. 2019;51:1193C1195. doi: 10.1016/j.transproceed.2019.01.092. [PubMed] [CrossRef] [Google Scholar] 2. Company EM (2018) Summary of product characteristicsShingrix. https://www.ema.europa.eu/en/documents/product-information/shingrix-epar-product-information_en.pdf. Zugegriffen: 18. M?rz 2020 3. Ambati A, Einarsdottir S, Magalhaes I, et al. Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients. Transpl Infect Dis. 2015;17:371C379. doi: 10.1111/tid.12382. [PubMed] [CrossRef] [Google Scholar] 4. Ammann AJ, Addiego J, Wara DW, et al. Polyvalent pneumococcal-polysaccharide immunization of individuals with sickle-cell individuals and anemia with splenectomy. N Engl J Med. 1977;297:897C900. doi: 10.1056/NEJM197710272971701. [PubMed] [CrossRef] [Google Scholar] 5. Anderson EJ. Rotavirus vaccines: viral losing and threat of transmission. Lancet Infect Dis. 2008;8:642C649. doi: 10.1016/S1473-3099(08)70231-7. [PubMed] [CrossRef] [Google Scholar] 6. Anderson H, Petrie K, Berrisford C, et al. Seroconversion after influenza vaccination in patients with lung cancer. Br J Cancer. 1999;80:219C220. doi: 10.1038/sj.bjc.6690342. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 7. Ando S. Efficiency of quadrivalent influenza vaccine predicated on the test-negative control research in children during the 2016C2017 season. J Infect Chemother. 2018;24:782C788. doi: 10.1016/j.jiac.2018.05.012. [PubMed] [CrossRef] [Google Scholar] 8. Antonelli NM, Dotters DJ, Katz VL, et al. Malignancy in pregnancy: a?overview of the literature. Component I. Obstet Gynecol Surv. 1996;51:125C134. doi: 10.1097/00006254-199602000-00022. [PubMed] [CrossRef] [Google Scholar] 9. Arnott A, Jones P, Franklin LJ, et al. A Registry for Sufferers With Asplenia/Hyposplenism Reduces the chance of Infections With Encapsulated Organisms. Clin Infect Dis. 2018;67:557C561. doi: 10.1093/cid/ciy141. [PubMed] [CrossRef] [Google Scholar] 10. Arslan M, Wiesner RH, Poterucha JJ, et al. Hepatitis A antibodies in liver transplant recipients: evidence for loss of immunity posttransplantation. Liver organ Transpl. 2000;6:191C195. doi: 10.1002/lt.500060216. [PubMed] [CrossRef] [Google Scholar] 11. Arslan M, Wiesner RH, Poterucha JJ, et al. Effectiveness and Security of hepatitis A vaccination in liver transplantation recipients. Transplantation. 2001;72:272C276. doi: 10.1097/00007890-200107270-00019. [PubMed] [CrossRef] [Google Scholar] 12. Aung AK, Trubiano JA, Spelman DW. Travel risk evaluation, information and vaccinations in immunocompromised holidaymakers (HIV, solid organ transplant and haematopoeitic stem cell transplant recipients): A review. Travel Med Infect Dis. 2015;13:31C47. doi: 10.1016/j.tmaid.2014.12.007. [PubMed] [CrossRef] [Google Scholar] 13. Australian Techie Advisory Group on Immunisation (ATAGI) Australian Immunisation Handbook. In: Wellness AGDo, editor. Vaccination for unique risk organizations. Canberra: Australian Authorities Department of Health; 2018. [Google Scholar] 14. Avelino-Silva VI, Freire Mda S, Rocha V, et al. Persistence of Yellowish Fever vaccine-induced antibodies after cable bloodstream stem cell transplant. Hum Vaccines Immunother. 2016;12:937C938. doi: 10.1080/21645515.2015.1112475. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 15. Avery RK. Influenza vaccines in the establishing of solid-organ transplantation: are they safe? Curr Opin Infect Dis. 2012;25:464C468. doi: 10.1097/QCO.0b013e328355a79b. [PubMed] [CrossRef] [Google Scholar] 16. Avery RK, Michaels M. Update on immunizations in solid organ transplant recipients: what clinicians need to find out. Am J Transplant. 2008;8:9C14. doi: 10.1111/j.1600-6143.2007.02051.x. [PubMed] [CrossRef] [Google Scholar] 17. Avetisyan G, Aschan J, Hassan M, et al. Evaluation of immune system reactions to seasonal influenza vaccination in healthy volunteers and in sufferers after stem cell transplantation. Transplantation. 2008;86:257C263. doi: 10.1097/TP.0b013e3181772a75. [PubMed] [CrossRef] [Google Scholar] 18. Azevedo LS, Lasmar EP, Contieri FL, et al. Yellowish fever vaccination in body organ transplanted sufferers: is it safe? A multicenter study. Transpl Infect Dis. 2012;14:237C241. doi: 10.1111/j.1399-3062.2011.00686.x. [PubMed] [CrossRef] [Google Scholar] 19. Baas MC, Truck Donselaar KA, Florquin S, et al. Mumps: no innocent bystander in solid body organ transplantation. Am J Transplant. 2009;9:2186C2189. doi: 10.1111/j.1600-6143.2009.02732.x. [PubMed] [CrossRef] [Google Scholar] 20. Backhaus E, Berg S, Andersson R, et al. Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age group, risk and gender factors. BMC Infect Dis. 2016;16:367. doi: 10.1186/s12879-016-1648-2. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 21. Balmer P, Falconer M, Mcdonald P, et al. Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals. Infect Immun. 2004;72:332C337. doi: 10.1128/IAI.72.1.332-337.2004. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 22. Barra A, Cordonnier C, Preziosi MP, et al. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone tissue marrow recipients. J INFECT DIS. 1992;166:1021C1028. doi: 10.1093/infdis/166.5.1021. [PubMed] [CrossRef] [Google Scholar] 23. Barton M, Wasfy S, Dipchand AI, et al. Seven-valent pneumococcal conjugate vaccine in pediatric solid organ transplant recipients: a?prospective study of immunogenicity and safety. Pediatr Infect Dis J. 2009;28:688C692. doi: 10.1097/INF.0b013e31819d97be. [PubMed] [CrossRef] [Google Scholar] 24. Bassetti M, Castaldo N, Carnelutti A. Neuraminidase inhibitors being a?technique for influenza treatment: advantages, cons and future perspectives. Opinion on Pharmacotherapy: Expert; 2019. pp. 1C8. [PubMed] [Google Scholar] 25. Bastidas A, De La El Serna Idrissi JM, et al. Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial. JAMA. 2019;322:123C133. doi: 10.1001/jama.2019.9053. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 26. Bate J, Baker S, Breuer J, et al. PEPtalk2: outcomes of the?pilot randomised controlled trial to review VZIG and aciclovir while postexposure prophylaxis (PEP) against chickenpox in children with malignancy. Arch Dis Child. 2019;104:25C29. doi: 10.1136/archdischild-2017-314212. [PubMed] [CrossRef] [Google Scholar] 27. Berglund A, Willen L, Grodeberg L, et al. The response to vaccination against influenza A(H1N1) 2009, seasonal Streptococcus and influenza pneumoniae in adult outpatients with ongoing treatment for cancers with and without rituximab. Acta Oncol. 2014;53:1212C1220. doi: 10.3109/0284186X.2014.914243. [PubMed] [CrossRef] [Google Scholar] 28. Berkowitz EM, Moyle G, Stellbrink HJ, et al. Basic safety and immunogenicity of the adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a?phase 1/2a randomized, placebo-controlled study. J INFECT DIS. 2015;211:1279C1287. doi: 10.1093/infdis/jiu606. [PMC free content] [PubMed] [CrossRef] [Google Scholar] 29. Bersanelli M, Buti S, De Giorgi U, et al. Condition of the artwork about influenza vaccination for advanced cancers patients receiving immune system checkpoint inhibitors: When good sense isn’t enough. Crit Rev Oncol Hematol. 2019;139:87C90. doi: 10.1016/j.critrevonc.2019.05.003. [PubMed] [CrossRef] [Google Scholar] 30. Bersanelli M, Giannarelli D, Castrignano P, et al. INfluenza Vaccine Indicator During therapy with Immune checkpoint inhibitors: a?transversal challenge. The INVIDIa study. Immunotherapy. 2018;10:1229C1239. doi: 10.2217/imt-2018-0080. [PubMed] [CrossRef] [Google Scholar] 31. Bhatia S, Louie AD, Bhatia R, et al. Solid cancers after bone tissue marrow transplantation. J Clin Oncol. 2001;19:464C471. doi: 10.1200/JCO.2001.19.2.464. [PubMed] [CrossRef] [Google Scholar] 32. Bisharat N, Omari H, Lavi I, et al. Risk of death and infection among post-splenectomy patients. J Infect. 2001;43:182C186. doi: 10.1053/jinf.2001.0904. [PubMed] [CrossRef] [Google Scholar] 33. Blevins LK, Wren JT, Holbrook BC, et al. Coinfection with Streptococcus pneumoniae adversely modulates the scale and composition from the ongoing influenza-specific Compact disc8(+) T cell response. J Immunol. 2014;193:5076C5087. doi: 10.4049/jimmunol.1400529. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 34. Blimark C, Holmberg E, Mellqvist UH, et al. Multiple myeloma and infections: a?population-based study on 9253 multiple myeloma individuals. Haematologica. 2015;100:107C113. doi: 10.3324/haematol.2014.107714. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 35. Bochennek K, Allwinn R, Langer R, et al. Differential lack of humoral immunity against measles, mumps, varicella-zoster and rubella virus in children treated for cancer. Vaccine. 2014;32:3357C3361. doi: 10.1016/j.vaccine.2014.04.042. [PubMed] [CrossRef] [Google Scholar] 36. Boeckh M, Kim HW, Bouquets Me personally, et al. Long-term acyclovir for avoidance of varicella zoster pathogen disease after allogeneic hematopoietic cell transplantationa randomized double-blind placebo-controlled study. Blood. 2006;107:1800C1805. doi: 10.1182/blood-2005-09-3624. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 37. Bonanni P, Grazzini M, Niccolai G, et al. Suggested vaccinations for hyposplenic and asplenic mature patients. Hum Vaccines Immunother. 2017;13:359C368. doi: 10.1080/21645515.2017.1264797. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 38. Branagan AR, Duffy E, Albrecht RA, et al. Clinical and Serologic Responses After a?Two-dose Group of High-dose Influenza Vaccine in Plasma Cell Disorders: A Potential, Single-arm Trial. Clin Lymphoma Myeloma Leuk. 2017;17:296C304.e292. doi: 10.1016/j.clml.2017.02.025. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 39. Briere EC, Rubin L, Moro PL, et al. Avoidance and control of haemophilus influenzae type b disease: recommendations of the advisory committee on immunization practices (ACIP). MMWR. Reports and Recommendations : Morbidity and mortality weekly statement. Recomm Reviews. 2014;63:1C14. [PubMed] [Google Scholar] 40. Bronte V, Pittet MJ. The spleen in regional and systemic legislation of immunity. Immunity. 2013;39:806C818. doi: 10.1016/j.immuni.2013.10.010. [PMC free of charge article] [PubMed] [CrossRef] [Google Scholar] 41. Broyer M, Tete MJ, Guest G, et al. Varicella and zoster in children after kidney transplantation: long-term results of vaccination. Pediatrics. 1997;99:35C39. doi: 10.1542/peds.99.1.35. [PubMed] [CrossRef] [Google Scholar] 42. Brydak LB, Guzy J, Starzyk J, et al. Humoral immune system response after vaccination against influenza in sufferers with breast cancer tumor. Support Care Cancer tumor. 2001;9:65C68. doi: 10.1007/s005200000186. [PubMed] [CrossRef] [Google Scholar] 43. Burchard GD, Caumes E, Connor BA, et al. Expert opinion on vaccination of travelers against Japanese encephalitis. J Travel Med. 2009;16:204C216. doi: 10.1111/j.1708-8305.2009.00330.x. [PubMed] [CrossRef] [Google Scholar] 44. Calaminus G, Hense B, Laws HJ, et al. Diphtheria (D) and tetanus (T) antibody ideals in children with severe lymphoblastic leukaemia (ALL) after treatment regarding to Co-ALL 05/92. Klin Padiatr. 2007;219:355C360. doi: 10.1055/s-2007-990290. [PubMed] [CrossRef] [Google Scholar] 45. Cameron PU, Jones P, Gorniak M, et al. Splenectomy linked adjustments in IgM storage B cells within an adult spleen registry cohort. Plos One. 2011;6:e23164. doi: 10.1371/journal.pone.0023164. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 46. Canadian Immunization Guideline: Part 3Vaccination of Specific Populace (2016) Immunization of Immunocompromised People. https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunizationguide-part-3-vaccination-specific-populations/page-8-immunization-immunocompromisedpersons.html#a15. Zugegriffen: 18. M?rz 2020 47. Carey W, Pimentel R, Westveer MK, et al. Failing of hepatitis B immunization in liver organ transplant recipients: outcomes of a?potential trial. Am J Gastroenterol. 1990;85:1590C1592. [PubMed] [Google Scholar] 48. Chakravarty EF, Murray ER, Kelman A, et al. Pregnancy final results after maternal exposure to rituximab. Blood. 2011;117:1499C1506. doi: 10.1182/blood-2010-07-295444. [PubMed] [CrossRef] [Google Scholar] 49. Chalasani N, Smallwood G, Halcomb J, et al. Is usually vaccination against hepatitis B contamination indicated in sufferers looking forward to or after orthotopic liver organ transplantation? Liver organ Transpl Surg. 1998;4:128C132. doi: 10.1002/lt.500040208. [PubMed] [CrossRef] [Google Scholar] 50. Cheng MP, Pandit A, Antin JH, et al. Basic safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantation. Blood Adv. 2018;2:1272C1276. doi: 10.1182/bloodadvances.2018018911. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 51. Chiou WY, Hung SK, Lai CL, et al. Aftereffect of 23-Valent Pneumococcal Polysaccharide Vaccine Inoculated During Anti-Cancer Treatment Period in Elderly Lung Cancers Sufferers on Community-Acquired Pneumonia Hospitalization: A Nationwide Population-Based Cohort Research. Medicine. 2015;94:e1022. doi: 10.1097/MD.0000000000001022. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 52. Chitasombat MN, Watcharananan SP. Final result and Prevalence of Disseminated Varicella Zoster An infection Post Kidney Transplantation. J Med Assoc Thai. 2016;99:381C385. [PubMed] [Google Scholar] 53. Choi DK, Fuleihan RL, Walterhouse Perform. Serologic response and scientific effectiveness of influenza vaccination in children and young adults on chemotherapy for malignancy. Pediatr Blood Cancer tumor. 2016;63:2011C2018. doi: 10.1002/pbc.26110. [PubMed] [CrossRef] [Google Scholar] 54. Chong CR, Recreation area VJ, Cohen B, et al. Basic safety of Inactivated Influenza Vaccine in Cancers Patients Receiving Defense Checkpoint Inhibitors (ICI) Clin Infect Dis. 2019;70:193C199. doi: 10.1093/cid/ciz202. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 55. Chong J, Jones P, Spelman D, et al. Overpowering post-splenectomy sepsis in sufferers with asplenia and hyposplenia: a?retrospective cohort research. Epidemiol Infect. 2017;145:397C400. doi: 10.1017/S0950268816002405. [PubMed] [CrossRef] [Google Scholar] 56. Chung C. To accomplish or never to perform: A concise upgrade of current medical controversies in immune system checkpoint blockade. J Oncol Pharm Pract. 2019;25:663C673. doi: 10.1177/1078155218786365. [PubMed] [CrossRef] [Google Scholar] 57. Concepcion BP, Schaefer HM. Looking after the pregnant kidney transplant recipient. Clin Transplant. 2011;25:821C829. doi: 10.1111/j.1399-0012.2011.01492.x. [PubMed] [CrossRef] [Google Scholar] 58. Copelovici Y, Strulovici D, Cristea AL, et al. Data on the efficiency of specific antimumps immunoglobulins in preventing mumps and of its problems. Virologie. 1979;30:171C177. [PubMed] [Google Scholar] 59. Cordero E, Aydillo TA, Perez-Ordonez A, et al. Deficient long-term response to pandemic vaccine outcomes in an inadequate antibody response to seasonal influenza vaccination in solid organ transplant recipients. Transplantation. 2012;93:847C854. doi: 10.1097/TP.0b013e318247a6ef. [PubMed] [CrossRef] [Google Scholar] 60. Cordero E, Roca-Oporto C, Bulnes-Ramos A, et al. Two Dosages of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant Recipients: Outcomes of TRANSGRIPE 1C2, a?Randomized Managed Clinical Trial. Clin Infect Dis. 2017;64:829C838. doi: 10.1093/cid/ciw855. [PubMed] [CrossRef] [Google Scholar] 61. Cordonnier C, Einarsdottir S, Cesaro S, et al. Vaccination of haemopoietic stem cell transplant recipients: recommendations from the 2017 European Conference on Infections in Leukaemia (ECIL 7) Lancet Infect Dis. 2019;19:e200Ce212. doi: 10.1016/S1473-3099(18)30600-5. [PubMed] [CrossRef] [Google Scholar] 62. Cordonnier C, Labopin M, Chesnel V, et al. Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation. Clin Infect Dis. 2009;48:1392C1401. doi: 10.1086/598324. [PubMed] [CrossRef] [Google Scholar] 63. Cordonnier C, Ljungman P, Juergens C, et al. Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine accompanied by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged /=2 years: an open-label research. Clin Infect Dis. 2015;61:313C323. doi: 10.1093/cid/civ287. [PMC free of charge article] [PubMed] [CrossRef] [Google Scholar] 64. Cornberg M, Protzer U, Petersen J, et al. Prophylaxis, therapy and medical diagnosis of hepatitis B pathogen infectionthe German guide. Z Gastroenterol. 2011;49:871C930. doi: 10.1055/s-0031-1273462. [PubMed] [CrossRef] [Google Scholar] 65. Coscia LA, Constantinescu S, Armenti DP, et al. The 25th Anniversary of the National Transplantation Pregnancy Registry. Clin Transpl. 2015;31:57C68. [PubMed] [Google Scholar] 66. Cramer CH, 2nd, Shieck V, Thomas SE, et al. Immune response to rabies vaccination in pediatric transplant patients. Pediatr Transplantation. 2008;12:874C877. doi: 10.1111/j.1399-3046.2008.00936.x. [PubMed] [CrossRef] [Google Scholar] 67. Crawford NW, Balloch A, Tikkanen L, et al. Pneumococcal conjugate vaccine administration during therapy for pediatric leukemia. Pediatr Infect Dis J. 2015;34:e9C15. doi: 10.1097/INF.0000000000000502. [PubMed] [CrossRef] [Google Scholar] 68. Croce E, Hatz C, Jonker EF, et al. Basic safety of live vaccinations on immunosuppressive therapy in sufferers with purchase LY2109761 immune-mediated inflammatory illnesses, solid body organ transplantation or after bone-marrow transplantationA organized review of randomized trials, observational research and case reviews. Vaccine. 2017;35:1216C1226. doi: 10.1016/j.vaccine.2017.01.048. [PubMed] [CrossRef] [Google Scholar] 69. Dagnew AF, Ilhan O, Lee WS, et al. Immunogenicity and basic safety from the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a?phase 3, randomised, clinical trial and post-hoc effectiveness analysis. Lancet Infect Dis. 2019;19:988C1000. doi: 10.1016/S1473-3099(19)30163-X. [PubMed] [CrossRef] [Google Scholar] 70. Daneshpouy M, Socie G, Clavel C, et al. Human being papillomavirus an infection and anogenital condyloma in bone tissue marrow transplant recipients. Transplantation. 2001;71:167C169. doi: 10.1097/00007890-200101150-00030. [PubMed] [CrossRef] [Google Scholar] 71. Danziger-Isakov L, Kumar D. Vaccination in solid body organ transplantation. Am J Transplant. 2013;13(4):311C317. doi: 10.1111/ajt.12122. [PubMed] [CrossRef] [Google Scholar] 72. Danziger-Isakov L, Kumar D, Practice AICo Vaccination of Solid Body organ Transplant Candidates and Recipients: Recommendations in the American Culture of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33:e13563. doi: 10.1111/ctr.13563. [PubMed] [CrossRef] [Google Scholar] 73. Davies JM, Lewis MP, Wimperis J, et al. Review of recommendations for the avoidance and treatment of an infection in individuals with an absent or dysfunctional spleen: prepared with respect to the United kingdom Committee for Criteria in Haematology with a?operating party of the Haemato-Oncology task force. Br J Haematol. 2011;155:308C317. doi: 10.1111/j.1365-2141.2011.08843.x. [PubMed] [CrossRef] [Google Scholar] 74. De Lavallade H, Garland P, Sekine T, et al. Repeated vaccination must optimize seroprotection against H1N1 in the immunocompromised sponsor. Haematologica. 2011;96:307C314. doi: 10.3324/haematol.2010.032664. [PMC free of charge article] [PubMed] [CrossRef] [Google Scholar] 75. De Silva IGS, Cole J, Stone Bj, Dockrell Dh, Vedio A. Successful usage of Fendrix in HIV-infected nonresponders to standard hepatitis B vaccines. J Infect. 2014;68:397C399. doi: 10.1016/j.jinf.2013.12.009. [PubMed] [CrossRef] [Google Scholar] 76. de Sousa MV, Zollner RL, Stucchi RSB, Boin I, de Ataide EC, Mazzali M. Yellow fever disease inside a renal transplant receiver: Case record and literature review. Transpl Infect Dis. 2019;21:e13151. doi: 10.1111/tid.13151. [PubMed] [CrossRef] [Google Scholar] 77. Decker M, Rothermundt C, Hollander G, et al. CHOP as well as Rituximab for treatment of diffuse huge B-cell lymphoma during second trimester of pregnancy. Lancet Oncol. 2006;7:693C694. doi: 10.1016/S1470-2045(06)70797-5. [PubMed] [CrossRef] [Google Scholar] 78. Dekkiche S, de Valliere S, D’Acremont V, Genton B. Travel-related health threats in moderately and severely immunocompromised patients: a case-control research. J Travel Med. 2016 doi: 10.1093/jtm/taw001. [PubMed] [CrossRef] [Google Scholar] 79. Den Haan JM, Kraal G. Innate immune system features of macrophage subpopulations in the spleen. J Innate Immun. 2012;4:437C445. doi: 10.1159/000335216. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 80. Dendle C, Stuart RL, Mulley WR, et al. Pneumococcal vaccination in adult solid organ transplant recipients: A review of current proof. Vaccine. 2018;36:6253C6261. doi: 10.1016/j.vaccine.2018.08.069. [PubMed] [CrossRef] [Google Scholar] 81. Dengler TJ, Zimmermann R, Meyer J, et al. Vaccination against tick-borne encephalitis under healing immunosuppression. Reduced efficiency in heart transplant recipients. Vaccine. 1999;17:867C874. doi: 10.1016/S0264-410X(98)00272-2. [PubMed] [CrossRef] [Google Scholar] 82. Deniset JF, Surewaard BG, Lee WY, et al. Splenic Ly6G(high) mature and Ly6G(int) immature neutrophils contribute to eradication of S. pneumoniae. J Exp Med. 2017;214:1333C1350. doi: 10.1084/jem.20161621. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 83. Di Cataldo A, Puleo S, Destri LG, et al. Splenic injury and mind-boggling postsplenectomy an infection. Br J Surg. 1987;74:343C345. doi: 10.1002/bjs.1800740504. [PubMed] [CrossRef] [Google Scholar] 84. Di Sabatino A, Carsetti R, Corazza GR. Post-splenectomy and hyposplenic claims. Lancet. 2011;378:86C97. doi: 10.1016/S0140-6736(10)61493-6. [PubMed] [CrossRef] [Google Scholar] 85. Diana A, Posfay-Barbe KM, Belli DC, et al. Vaccine-induced immunity in children after orthotopic liver organ transplantation: a?12-yr overview of the Swiss nationwide reference middle. Pediatr Transplantation. 2007;11:31C37. doi: 10.1111/j.1399-3046.2006.00596.x. [PubMed] [CrossRef] [Google Scholar] 86. Dinelli MIS, Dos SAMN, Weckx LY, et al. Safe administration of rotavirus vaccine inside a?cohort of newborns subjected to immunosuppressive medications during gestation. Transpl Infect Dis. 2018;20:e12951. doi: 10.1111/tid.12951. [PubMed] [CrossRef] [Google Scholar] 87. Dos Santos G, Haguinet F, Cohet C, et al. Risk of solid organ transplant rejection following vaccination with seasonal trivalent inactivated influenza vaccines in England: A self-controlled case-series. Vaccine. 2016;34:3598C3606. doi: 10.1016/j.vaccine.2016.05.016. [PubMed] [CrossRef] [Google Scholar] 88. Douglas AP, Trubiano JA, Barr I, et al. Ibrutinib may impair serological reactions to influenza vaccination. Haematologica. 2017;102:e397Ce399. doi: 10.3324/haematol.2017.164285. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 89. Dumont-Girard F, Roux E, Vehicle Lier RA, et al. Reconstitution from the T-cell compartment after bone marrow transplantation: restoration from the repertoire by thymic emigrants. Bloodstream. 1998;92:4464C4471. doi: 10.1182/blood.V92.11.4464. [PubMed] [CrossRef] [Google Scholar] 90. Dumot JA, Barnes DS, Younossi Z, et al. Immunogenicity of hepatitis A vaccine in decompensated liver disease. Am J Gastroenterol. 1999;94:1601C1604. doi: 10.1111/j.1572-0241.1999.01150.x. [PubMed] [CrossRef] [Google Scholar] 91. Earle CC. Influenza vaccination in elderly sufferers with advanced colorectal tumor. J Clin Oncol. 2003;21:1161C1166. doi: 10.1200/JCO.2003.06.008. [PubMed] [CrossRef] [Google Scholar] 92. Eckerle I, Rosenberger KD, Zwahlen M, et al. Serologic vaccination response after solid organ transplantation: a?systematic review. Plos One. 2013;8:e56974. doi: 10.1371/journal.pone.0056974. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 93. Edgren G, Almqvist R, Hartman M, et al. Splenectomy and the chance of sepsis: a?population-based cohort study. Ann Surg. 2014;260:1081C1087. doi: 10.1097/SLA.0000000000000439. [PubMed] [CrossRef] [Google Scholar] 94. Ehl S, Bogdan C, Niehues T, et al. Impfen bei Immundefizienz: Anwendungshinweise zu den von der St?ndigen Impfkommission empfohlenen Impfungen. (II) Impfen bei 1. Prim?ren Immundefekterkrankungen und 2. HIV-Infektion. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61:1034C1051. doi: 10.1007/s00103-018-2807-y. [PubMed] [CrossRef] [Google Scholar] 95. Ejstrud P, Kristensen B, Hansen JB, et al. Risk and patterns of bacteraemia after splenectomy: a?population-based study. Scand J Infect Dis. 2000;32:521C525. doi: 10.1080/003655400458811. [PubMed] [CrossRef] [Google Scholar] 96. Ek T, Mellander L, Andersson B, et al. Immune reconstitution after child years acute lymphoblastic leukemia is certainly most significantly affected in the risky group. Pediatr Blood Malignancy. 2005;44:461C468. doi: 10.1002/pbc.20255. [PubMed] [CrossRef] [Google Scholar] 97. Ek T, Mellander L, Hahn-Zoric M, et al. Avidity of Hib and tetanus antibodies after youth acute lymphoblastic leukaemiaimplications for vaccination strategies. Acta Paediatr. 2006;95:701C706. doi: 10.1080/08035250500459717. [PubMed] [CrossRef] [Google Scholar] 98. Ek T, Mellander L, Hahn-Zoric M, et al. Intensive treatment for child years acute lymphoblastic leukemia reduces immune replies to diphtheria, tetanus, and Haemophilus influenzae type b. J Pediatr Hematol Oncol. 2004;26:727C734. doi: 10.1097/00043426-200411000-00008. [PubMed] [CrossRef] [Google Scholar] 99. Un Hoss S, Dussiot M, Renaud O, et al. A book noninvasive solution to measure splenic filtration function in humans. Haematologica. 2018;103:e436Ce439. doi: 10.3324/haematol.2018.188920. [PMC free content] [PubMed] [CrossRef] [Google Scholar] 100. Engelhard D, Cordonnier C, Shaw PJ, et al. Early and past due invasive pneumococcal an infection pursuing stem cell transplantation: a?Western Bone tissue Marrow Transplantation survey. Br J Haematol. 2002;117:444C450. doi: 10.1046/j.1365-2141.2002.03457.x. [PubMed] [CrossRef] [Google Scholar] 101. Engelhard D, Mohty B, De La Camara R, et al. Western guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: overview of ECIL-4 (2011), with respect to ECIL, a?jv of EBMT, EORTC, ICHS, and ELN. Transpl Infect Dis. 2013;15:219C232. doi: 10.1111/tid.12054. [PubMed] [CrossRef] [Google Scholar] 102. Engelhard D, Zakay-Rones Z, Shapira MY, et al. The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic. Vaccine. 2011;29:1777C1782. doi: 10.1016/j.vaccine.2010.12.113. [PubMed] [CrossRef] [Google Scholar] 103. Eperon GBS, Enriquez N, Vaudaux B. Voyageur immunosupprim?: recommandations vaccinales. Rev Med Suisse. 2018;14:922C933. [PubMed] [Google Scholar] 104. Esposito S, Tenconi R, Preti V, et al. Chemotherapy against tumor during being pregnant: A organized review on neonatal outcomes. Medicine. 2016;95:e4899. doi: 10.1097/MD.0000000000004899. [PMC free content] [PubMed] [CrossRef] [Google Scholar] 105. Western Medicinces Company (2018) Evaluation ReportShingrix. 106. Eyrich M, Wiegering V, Lim A, et al. Immune function in children under chemotherapy for standard risk severe lymphoblastic leukaemiaa?potential research of 20 paediatric patients. Br J Haematol. 2009;147:360C370. doi: 10.1111/j.1365-2141.2009.07862.x. [PubMed] [CrossRef] [Google Scholar] 107. Fabrizi F, Dixit V, Bunnapradist S, et al. Meta-analysis: the dialysis mode and immunological response to hepatitis B computer virus vaccine in dialysis inhabitants. Aliment Pharmacol Ther. 2006;23:1105C1112. doi: 10.1111/j.1365-2036.2006.02877.x. [PubMed] [CrossRef] [Google Scholar] 108. Feldman S, Gigliotti F, Shenep JL, et al. Threat of Haemophilus influenzae type b disease in kids with malignancy and response of immunocompromised leukemic children to a?conjugate vaccine. J INFECT DIS. 1990;161:926C931. doi: 10.1093/infdis/161.5.926. [PubMed] [CrossRef] [Google Scholar] 109. Forstner C, Plefka S, Tobudic S, et al. Efficiency and immunogenicity of pneumococcal vaccination in splenectomized and asplenic sufferers functionally. Vaccine. 2012;30:5449C5452. doi: 10.1016/j.vaccine.2012.06.048. [PubMed] [CrossRef] [Google Scholar] 110. Galea SA, Special A, Beninger P, et al. The security profile of varicella vaccine: a?10-year review. J INFECT DIS. 2008;197(2):165C169. doi: 10.1086/522125. [PubMed] [CrossRef] [Google Scholar] 111. Gandhi MK, Egner W, Sizer L, et al. Antibody replies to vaccinations given within the 1st two years after transplant are very similar between autologous peripheral bloodstream stem cell and bone marrow transplant recipients. Bone Marrow Transplant. 2001;28:775C781. doi: 10.1038/sj.bmt.1703239. [PubMed] [CrossRef] [Google Scholar] 112. Garcia Garrido HM, Veurink AM, Leeflang M, Spijker R, Goorhuis A, Grobusch MP. Hepatitis A vaccine immunogenicity in sufferers using immunosuppressive medications: A organized critique and meta-analysis. Travel Med Infect Dis. 2019 doi: 10.1016/j.tmaid.2019.101479. [PubMed] [CrossRef] [Google Scholar] 113. Garcia Garrido HM, Wieten RW, Grobusch MP, et al. Response to Hepatitis A Vaccination in Immunocompromised Travelers. J INFECT DIS. 2015;212:378C385. doi: 10.1093/infdis/jiv060. [PubMed] [CrossRef] [Google Scholar] 114. Geretti AM, Brook G, Cameron C, et al. United kingdom HIV Association Suggestions purchase LY2109761 on the usage of Vaccines in HIV-Positive Adults 2015. HIV Med. 2016;17(3):2C81. doi: 10.1111/hiv.12424. [PubMed] [CrossRef] [Google Scholar] 115. Gil L, Styczynski J, Komarnicki M. Infectious problem in 314 sufferers after high-dose therapy and autologous hematopoietic stem cell transplantation: risk elements analysis and result. Disease. 2007;35:421C427. doi: 10.1007/s15010-007-6350-2. [PubMed] [CrossRef] [Google Scholar] 116. Gollwitzer Sera, Marsland BJ. Impact of Early-Life Exposures on Immune Maturation and Susceptibility to Disease. Trends Immunol. 2015;36:684C696. doi: 10.1016/j.it.2015.09.009. [PubMed] [CrossRef] [Google Scholar] 117. Goossen GM, Kremer LC, vehicle de Wetering MD. Influenza vaccination in kids becoming treated with chemotherapy for tumor. Cochrane Data source Syst Rev. 2013 doi: 10.1002/14651858.CD006484.pub3. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 118. Gordon MA. Salmonella infections in immunocompromised adults. J Infect. 2008;56:413C422. doi: 10.1016/j.jinf.2008.03.012. [PubMed] [CrossRef] [Google Scholar] 119. Gowda R, Cartwright K, Bremner JA, et al. Yellow fever vaccine: a?successful vaccination of an immunocompromised patient. Eur J Haematol. 2004;72:299C301. doi: 10.1111/j.1600-0609.2004.00218.x. [PubMed] [CrossRef] [Google Scholar] 120. Greenwood KP, Hafiz R, Ware RS, et al. A systematic review of human-to-human transmitting of measles vaccine pathogen. Vaccine. 2016;34:2531C2536. doi: 10.1016/j.vaccine.2016.03.092. [PubMed] [CrossRef] [Google Scholar] 121. Gsk (2019) Rabipur C Fachinformation. 122. Gunther M, Neuhaus R, Bauer T, et al. Immunization with an adjuvant hepatitis B vaccine in liver organ transplant recipients: antibody decline and booster vaccination with conventional vaccine. Liver organ Transpl. 2006;12:316C319. doi: 10.1002/lt.20674. [PubMed] [CrossRef] [Google Scholar] 123. Gunther M, Stark K, Neuhaus R, et al. Fast drop of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation. 2001;71:477C479. doi: 10.1097/00007890-200102150-00023. [PubMed] [CrossRef] [Google Scholar] 124. Gwyn K. Children Exposed to Chemotherapy In Utero. Jnci Monogr. 2005;2005:69C71. doi: 10.1093/jncimonographs/lgi009. [PubMed] [CrossRef] [Google Scholar] 125. Gwynn Me personally, DeRemer DL, Saunders Kilometres, Parikh J, Bollag RJ, Clemmons AB. Immune-mediated adverse events pursuing influenza vaccine in cancers patients receiving immune system checkpoint inhibitors. J Oncol Pharm Pract. 2019 doi: 10.1177/1078155219868758. [PubMed] [CrossRef] [Google Scholar] 126. Hakim H, Dallas R, Zhou Y, et al. Acute respiratory infections in children and children with severe lymphoblastic leukemia. Malignancy. 2016;122:798C805. doi: 10.1002/cncr.29833. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 127. Halasa NB, Shankar SM, Talbot TR, et al. Occurrence of intrusive pneumococcal disease among people with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2007;44:1428C1433. doi: 10.1086/516781. [PubMed] [CrossRef] [Google Scholar] 128. Hamaguchi Y, Mori A, Uemura T, et al. Occurrence and risk elements for herpes zoster in sufferers undergoing liver transplantation. Transpl Infect Dis. 2015;17:671C678. doi: 10.1111/tid.12425. [PubMed] [CrossRef] [Google Scholar] 129. Han CS, Miller W, Haake R, et al. Varicella zoster illness after bone marrow transplantation: incidence, risk factors and complications. Bone Marrow Transplant. 1994;13:277C283. [PubMed] [Google Scholar] 130. Hansson KE, Rosdahl A, Insulander M, et al. Tick-borne Encephalitis Vaccine Failures: A 10-yr Retrospective Study Assisting the explanation for Adding an Extra Priming Dose in Individuals Beginning at Age group 50 Years. Clin Infect Dis. 2020;70:245C251. doi: 10.1093/cid/ciz176. [PMC free of charge article] [PubMed] [CrossRef] [Google Scholar] 131. Haut Conseil De La Sant Publique (2014) Vaccination des personnes immunodprimes ou asplniquesRecommandations. 132. Hayakawa K, Takasaki T, Tsunemine H, et al. Persistent seropositivity for yellowish fever in a?previously vaccinated autologous hematopoietic stem cell transplantation recipient. Int J Infect Dis. 2015;37:9C10. doi: 10.1016/j.ijid.2015.05.025. [PubMed] [CrossRef] [Google Scholar] 133. Helou E, Offer M, Landry M, Wu X, Morrow JS, Malinis MF. Fatal case of cutaneous-sparing orolaryngeal zoster within a renal transplant recipient. Transpl Infect Dis. 2017 doi: 10.1111/tid.12704. [PubMed] [CrossRef] [Google Scholar] 134. Hernandez MC, Khasawneh M, Contreras-Peraza N, et al. Splenectomy and Vaccination in Olmsted County. Medical operation. 2019;166:556C563. doi: 10.1016/j.surg.2019.04.046. [PubMed] [CrossRef] [Google Scholar] 135. Hertzell KB, Pauksens K, Rombo L, et al. Tick-borne encephalitis (TBE) vaccine to clinically immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre research. Vaccine. 2016;34:650C655. doi: 10.1016/j.vaccine.2015.12.029. [PubMed] [CrossRef] [Google Scholar] 136. Hilgendorf I, Freund M, Jilg W, et al. Vaccination of allogeneic haematopoietic stem cell transplant recipients: survey from the worldwide consensus conference on clinical practice in chronic GVHD. Vaccine. 2011;29:2825C2833. doi: 10.1016/j.vaccine.2011.02.018. [PubMed] [CrossRef] [Google Scholar] 137. Holdsworth RJ, Irving Advertisement, Cuschieri A. Postsplenectomy sepsis and its own mortality price: actual versus perceived risks. Br J Surg. 1991;78:1031C1038. doi: 10.1002/bjs.1800780904. [PubMed] [CrossRef] [Google Scholar] 138. Hung TY, Kotecha RS, Blyth CC, et al. Security and Immunogenicity of single-dose, 13-valent pneumococcal conjugate vaccine in pediatric and adolescent oncology sufferers. Malignancy. 2017;123:4215C4223. doi: 10.1002/cncr.30764. [PubMed] [CrossRef] [Google Scholar] 139. Hurst FP, Lee JJ, Jindal RM, et al. Results connected with influenza vaccination in the initial calendar year after kidney transplantation. Clin J Am Soc Nephrol. 2011;6:1192C1197. doi: 10.2215/CJN.05430610. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 140. Huzly D, Neifer S, Reinke P, et al. Program immunizations in adult renal transplant recipients. Transplantation. 1997;63:839C845. doi: 10.1097/00007890-199703270-00008. [PubMed] [CrossRef] [Google Scholar] 141. Ilan Y, Nagler A, Zeira E, et al. Maintenance of immune system memory towards the hepatitis B envelope proteins following adoptive transfer of immunity in bone marrow transplant recipients. Bone tissue Marrow Transplant. 2000;26:633C638. doi: 10.1038/sj.bmt.1702571. [PubMed] [CrossRef] [Google Scholar] 142. Inaba H, Hartford CM, Pei D, et al. Longitudinal evaluation of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2012;156:109C117. doi: 10.1111/j.1365-2141.2011.08913.x. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 143. Ison MG, Szakaly P, Shapira MY, et al. Safety and Efficacy of oral oseltamivir for influenza prophylaxis in transplant recipients. Antivir Ther. 2012;17:955C964. doi: 10.3851/IMP2192. [PubMed] [CrossRef] [Google Scholar] 144. Ito K, Mugitani A, Irie S, et al. Prior vaccinations improve immunogenicity of inactivated influenza vaccine in small children aged 6?weeks to 3 years: A cohort study. Medicine. 2018;97:e11551. doi: 10.1097/MD.0000000000011551. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 145. Jeon HJ, Ro H, Jeong JC, et al. Effectiveness and protection of hepatitis A vaccination in kidney transplant recipients. Transpl Infect Dis. 2014;16:511C515. doi: 10.1111/tid.12217. [PubMed] [CrossRef] [Google Scholar] 146. Jochems SP, Marcon F, Carniel BF, et al. Swelling induced by influenza pathogen impairs human innate immune control of pneumococcus. Nat Immunol. 2018;19:1299C1308. doi: 10.1038/s41590-018-0231-y. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 147. Jonker EF, Visser LG, Roukens AH. Controversies and Advances in yellow fever vaccination. Ther Adv Vaccines. 2013;1:144C152. doi: 10.1177/2051013613498954. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 148. Jonker EFF, Uijlings Visser MCLG, et al. Comparison of the immunogenicity of Dukoral(R) oral cholera vaccine between renal transplant recipients on either a?calcineurin inhibitor or mycophenolateA controlled trial. Vaccine. 2019;37:3133C3139. doi: 10.1016/j.vaccine.2019.04.010. [PubMed] [CrossRef] [Google Scholar] 149. Kaatsch PGD, Spix C. Deutsches Kinderkrebsregister. Mainz: Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI) on the University INFIRMARY from the Johannes Gutenberg University or college; 2019. German Childhood Malignancy RegistryAnnual Statement 2018 (1980C2017) [Google Scholar] 150. Kamboj M, Shah MK. Vaccination from the Stem Cell Transplant Receiver as well as the Hematologic Malignancy Patient. Infect Dis Clin North Am. 2019;33:593C609. doi: 10.1016/j.idc.2019.02.007. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 151. Kanda Y, Mineishi S, Saito T, et al. Long-term low-dose acyclovir against varicella-zoster trojan reactivation after allogeneic hematopoietic stem cell transplantation. Bone tissue Marrow Transplant. 2001;28:689C692. doi: 10.1038/sj.bmt.1703214. [PubMed] [CrossRef] [Google Scholar] 152. Kang G, Chen H, Ma F, et al. Assessment of the effect of elevated hepatitis B vaccine medication dosage on immunogenicity in healthful kids and adults. Hum Vaccines Immunother. 2016;12:2312C2316. doi: 10.1080/21645515.2016.1172757. [PMC free content] [PubMed] [CrossRef] [Google Scholar] 153. Kang M, Aslam S. Varicella zoster disease encephalitis in purchase LY2109761 solid body organ transplant recipients: Case series and review of literature. Transpl Infect Dis. 2019;21:e13038. doi: 10.1111/tid.13038. [PubMed] [CrossRef] [Google Scholar] 154. Kano H, Mizuta K, Sakakihara Y, et al. Efficacy and security of immunization for pre- and post-liver transplant kids. Transplantation. 2002;74:543C550. doi: 10.1097/00007890-200208270-00020. [PubMed] [CrossRef] [Google Scholar] 155. Kaul A, Sharma RK, Bhadhuria D, et al. Chickenpox illness after renal transplantation. Clin Kidney J. 2012;5:203C206. doi: 10.1093/ckj/sfs036. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 156. Kavaliotis J, Loukou I, Trachana M, et al. Outbreak of varicella inside a?pediatric oncology device. Med Pediatr Oncol. 1998;31:166C169. doi: 10.1002/(SICI)1096-911X(199809)31:3 166::AID-MPO7 3.0.CO;2-9. [PubMed] [CrossRef] [Google Scholar] 157. Kawamura K, Yamazaki R, Akahoshi Y, et al. Evaluation from the immune position against measles, mumps, and rubella in adult allogeneic hematopoietic stem cell transplantation recipients. Hematology. 2015;20:77C82. doi: 10.1179/1607845414Y.0000000174. [PubMed] [CrossRef] [Google Scholar] 158. Kawano Y, Suzuki M, Kawada J, et al. Security and Effectiveness of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients. Vaccine. 2015;33:1440C1445. doi: 10.1016/j.vaccine.2015.01.075. [PubMed] [CrossRef] [Google Scholar] 159. Kidd IM, Booth CJ, Rigden SP, et al. Measles-associated encephalitis in kids with renal transplants: a?predictable aftereffect of waning herd immunity? Lancet. 2003;362:832. doi: 10.1016/S0140-6736(03)14256-0. [PubMed] [CrossRef] [Google Scholar] 160. Kim DK, Riley LE, Harriman KH, et al. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or OlderUnited States, 2017. Mmwr Morb Mortal Wkly Rep. 2017;66:136C138. doi: 10.15585/mmwr.mm6605e2. [PMC free content] [PubMed] [CrossRef] [Google Scholar] 161. Kim W, Kim S, Oh J, et al. Risk and Incidence factors for herpes zoster after adult liver organ transplantation. Ann Surg Treat Res. 2019;96:95C99. doi: 10.4174/astr.2019.96.2.95. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 162. Kimby E, Sverrisdottir A, Elinder G. Protection of rituximab therapy during the first trimester of being pregnant: An instance background. Eur J Haematol. 2004;72:292C295. doi: 10.1111/j.1600-0609.2004.00214.x. [PubMed] [CrossRef] [Google Scholar] 163. Kling K, Wichmann O, Burchard G. Reiseimpfungen fr besondere Personengruppen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020;63:85C92. doi: 10.1007/s00103-019-03067-w. [PubMed] [CrossRef] [Google Scholar] 164. Klink DT, Van Elburg RM, Schreurs MW, et al. Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell advancement. Clin Dev Immunol. 2008;2008:271363. doi: 10.1155/2008/271363. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 165. Knight A, Pauksens K, Nordmark G, et al. Fatal final result of tick-borne encephalitis in two patients with rheumatic disease treated with rituximab. Rheumatology. 2017;56:855C856. [PubMed] [Google Scholar] 166. Koc Y, Miller KB, Schenkein DP, et al. Varicella zoster computer virus infections pursuing allogeneic bone tissue marrow transplantation: regularity, risk factors, and clinical end result. Biol Blood Marrow Transplant. 2000;6:44C49. doi: 10.1016/S1083-8791(00)70051-6. [PubMed] [CrossRef] [Google Scholar] 167. Koo S, Gagne LS, Lee P, et al. Risk and Incidence factors for herpes zoster following heart transplantation. Transpl Infect Dis. 2014;16:17C25. doi: 10.1111/tid.12149. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 168. Kopel E, Oren G, Sidi Y, et al. Inadequate antibody response to rabies vaccine in immunocompromised patient. Growing Infect Dis. 2012;18:1493C1495. doi: 10.3201/eid1809.111833. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 169. Kotton CN. Immunization and Vaccination against travel-related illnesses in immunocompromised hosts. Expert Rev Vaccines. 2008;7:663C672. doi: 10.1586/14760584.7.5.663. [PubMed] [CrossRef] [Google Scholar] 170. Kotton CNKA, Freedman DO. Travelers with Additional Considerations – Immunocompromised Travelers. In: Brunette GWNJ, editor. CDC Yellowish Book 2020: Wellness Details for International Travel. NY: Oxford College or university Press; 2020. [Google Scholar] 171. Barnes B, Kraywinkel K, Nowossadeck E, et al. Bericht zum Krebsgeschehen in Deutschland 2016. Berlin: Robert Koch-Institut; 2016. [Google Scholar] 172. Kristensen K. Antibody response to a?Haemophilus influenzae type b polysaccharide tetanus toxoid conjugate vaccine in splenectomized adolescents and children. Scand J Infect Dis. 1992;24:629C632. doi: 10.3109/00365549209054649. [PubMed] [CrossRef] [Google Scholar] 173. Kristinsson SY, Gridley G, Hoover RN, et al. Long-term risks after splenectomy among 8,149 cancer-free American veterans: a?cohort research with to 27 years follow-up up. Haematologica. 2014;99:392C398. doi: 10.3324/haematol.2013.092460. [PMC free of charge article] [PubMed] [CrossRef] [Google Scholar] 174. Kroger AT, Sumaya CV, Pickering LK, et al. General recommendations on immunizationrecommendations of the Advisory Committee on Immunization Methods (ACIP). MMWR. Suggestions and reviews : Morbidity and mortality weekly report. Recomm Reports. 2011;60:1C64. [PubMed] [Google Scholar] 175. Kroon FP, Truck Dissel JT, Labadie J, et al. Antibody response to diphtheria, tetanus, and poliomyelitis vaccines with regards to the amount of CD4+ T lymphocytes in adults infected with human immunodeficiency pathogen. Clin Infect Dis. 1995;21:1197C1203. doi: 10.1093/clinids/21.5.1197. [PubMed] [CrossRef] [Google Scholar] 176. Kuchar E, Miskiewicz K, Karlikowska M. A review of guidance on immunization in people with lacking or defective splenic function. Br J Haematol. 2015;171:683C694. doi: 10.1111/bjh.13660. [PubMed] [CrossRef] [Google Scholar] 177. Kulkarni S, Powles R, Treleaven J, et al. Chronic graft versus sponsor disease is associated with long-term risk for pneumococcal infections in recipients of bone tissue marrow transplants. Bloodstream. 2000;95:3683C3686. doi: 10.1182/bloodstream.V95.12.3683. [PubMed] [CrossRef] [Google Scholar] 178. Kumar A, Moulik NR, Verma N. Successful prevention of varicella outbreak in an overcrowded paediatric oncology ward using oral acyclovir prophylaxis. J Trop Pediatr. 2015;61:151. doi: 10.1093/tropej/fmv008. [PubMed] [CrossRef] [Google Scholar] 179. Kumar D, Blumberg EA, Danziger-Isakov L, et al. Influenza vaccination in the body organ transplant receiver: review and summary recommendations. Am J Transplant. 2011;11:2020C2030. doi: 10.1111/j.1600-6143.2011.03753.x. [PubMed] [CrossRef] [Google Scholar] 180. Kumar D, Humar A, Plevneshi A, et al. Invasive pneumococcal disease in solid organ transplant recipients10-calendar year prospective population security. Am J Transplant. 2007;7:1209C1214. doi: 10.1111/j.1600-6143.2006.01705.x. [PubMed] [CrossRef] [Google Scholar] 181. Kumar D, Humar A, Plevneshi A, et al. Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a?decade of prospective population-based monitoring. Bone Marrow Transplant. 2008;41:743C747. doi: 10.1038/sj.bmt.1705964. [PubMed] [CrossRef] [Google Scholar] 182. Kumar D, Michaels MG, Morris MI, et al. Outcomes from pandemic influenza A H1N1 disease in recipients of solid-organ transplants: a?multicentre cohort research. The Lancet. Infect Dis. 2010;10:521C526. [PMC free of charge article] [PubMed] [Google Scholar] 183. Kyaw MH, Holmes EM, Toolis F, et al. Evaluation of severe infection and success after splenectomy. Am J Med. 2006;119(276):e271C277. [PubMed] [Google Scholar] 184. Lhuillier AG, Kumar D. Immunizations in solid organ and hematopoeitic stem cell transplant patients: A thorough review. Hum Vaccines Immunother. 2015;11:2852C2863. doi: 10.1080/21645515.2015.1078043. [PMC free of charge article] [PubMed] [CrossRef] [Google Scholar] 185. Lhuillier AG, Posfay BK. Live viral vaccines in transplanted patients. Swiss Med Wkly. 2014;144:w14005. [PubMed] [Google Scholar] 186. La Nasa M, Gaughan J, Cardonick E. Incidence of Neonatal Leukopenia and Neutropenia After In Utero Exposure to Chemotherapy for Maternal Cancer. Am J Clin Oncol. 2019;42:351C354. doi: 10.1097/COC.0000000000000527. [PubMed] [CrossRef] [Google Scholar] 187. Langley JM, Dodds L, Fell D, et al. Pneumococcal and influenza immunization in asplenic people: a?retrospective population-based cohort research 1990C2002. BMC Infect Dis. 2010;10:219. doi: 10.1186/1471-2334-10-219. [PMC free of charge article] [PubMed] [CrossRef] [Google Scholar] 188. L?ubli H, Balmelli C, Kaufmann L, et al. Influenza vaccination of cancer patients during PD-1 blockade induces serological security but may improve the risk for immune-related undesirable events. J Immunother Malignancy. 2018;6:40C40. doi: 10.1186/s40425-018-0353-7. [PMC free content] [PubMed] [CrossRef] [Google Scholar] 189. Laws and regulations HJ, Calaminus G, Gobel U. Evaluation of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Malignancy. 2005;103:1759. doi: 10.1002/cncr.21017. [PubMed] [CrossRef] [Google Scholar] 190. Laws HJ, Simon A, Lehrnbecher T. Revaccination in Kids Going through Autologous Tbp Hematopoietic Stem Cell Transplantation: Outcomes of a Survey in Germany, Austria and Switzerland. Klin Padiatr. 2019;231:136C141. doi: 10.1055/a-0796-6719. [PubMed] [CrossRef] [Google Scholar] 191. Le Corre N, Thibault F, Pouteil NC, et al. Effect of two shots of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial. Vaccine. 2012;30:7522C7528. doi: 10.1016/j.vaccine.2012.10.047. [PubMed] [CrossRef] [Google Scholar] 192. Lehrnbecher T, Foster C, Vazquez N, et al. Therapy-induced modifications in host protection in children receiving therapy for cancers. J Pediatr Hematol Oncol. 1997;19:399C417. doi: 10.1097/00043426-199709000-00001. [PubMed] [CrossRef] [Google Scholar] 193. Lehrnbecher T, Schubert R, Allwinn R, et al. Revaccination of kids after completion of standard chemotherapy for acute lymphoblastic leukaemia: a?pilot study looking at different schedules. Br J Haematol. 2011;152:754C757. doi: 10.1111/j.1365-2141.2010.08522.x. [PubMed] [CrossRef] [Google Scholar] 194. Lehrnbecher T, Schubert R, Behl M, et al. Impaired pneumococcal immunity in kids after treatment for severe lymphoblastic leukaemia. Br J Haematol. 2009;147:700C705. doi: 10.1111/j.1365-2141.2009.07903.x. [PubMed] [CrossRef] [Google Scholar] 195. Leone G, Pizzigallo E. Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic Diseases. Mediterr J Hematol Infect Dis. 2015;7:e2015057. doi: 10.4084/mjhid.2015.057. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 196. Lewensohn-Fuchs I, Ljungman P, Kjerrstrom A, et al. Lack of seroreactivity against human being papillomavirus (HPV) in bone tissue marrow transplant recipients. Bone tissue Marrow Transplant. 1996;18:333C337. [PubMed] [Google Scholar] 197. Lin KY, Chen GJ, Lee YL, et al. Hepatitis A trojan illness and hepatitis A vaccination in human being immunodeficiency virus-positive individuals: A review. WJG. 2017;23:3589C3606. doi: 10.3748/wjg.v23.i20.3589. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 198. Lindemann M, Heinemann FM, Horn PA, et al. Long-term response to vaccination against pneumococcal antigens in kidney transplant recipients. Transplantation. 2012;94:50C56. doi: 10.1097/TP.0b013e318250fc8c. [PubMed] [CrossRef] [Google Scholar] 199. Lindstrom V, Aittoniemi J, Lyytikainen O, et al. Invasive pneumococcal disease in individuals with haematological malignancies before routine use of conjugate vaccines in Finland. Infect Dis. 2016;48:399C402. doi: 10.3109/23744235.2015.1115894. [PubMed] [CrossRef] [Google Scholar] 200. Linet MS, Nyren O, Gridley G, et al. Causes of death among sufferers making it through at least twelve months following splenectomy. Am J Surg. 1996;172:320C323. doi: 10.1016/S0002-9610(96)00196-1. [PubMed] [CrossRef] [Google Scholar] 201. Linnemann CC, Jr., First MR. Risk of pneumococcal infections in renal transplant patients. JAMA. 1979;241:2619C2621. doi: 10.1001/jama.1979.03290500027016. [PubMed] [CrossRef] [Google Scholar] 202. Linnemann CC, Jr., First MR, Schiffman G. Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine. Arch Intern Med. 1986;146:1554C1556. doi: 10.1001/archinte.1986.00360200116019. [PubMed] [CrossRef] [Google Scholar] 203. Lipowski D, Popiel M, Perlejewski K, et al. A Cluster of Fatal Tick-borne Encephalitis Disease Infection in Body organ Transplant Establishing. J INFECT DIS. 2017;215:896C901. doi: 10.1093/infdis/jix040. [PubMed] [CrossRef] [Google Scholar] 204. Ljungman P, Aschan J, Barkholt L, et al. Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease. Bone tissue Marrow Transplant. 2004;34:589C593. doi: 10.1038/sj.bmt.1704634. [PubMed] [CrossRef] [Google Scholar] 205. Ljungman P, Avetisyan G. Influenza vaccination in hematopoietic SCT recipients. Bone tissue Marrow Transplant. 2008;42:637C641. doi: 10.1038/bmt.2008.264. [PubMed] [CrossRef] [Google Scholar] 206. Ljungman P, Cordonnier C, Einsele H, et al. Vaccination of hematopoietic cell transplant recipients. Bone tissue Marrow Transplant. 2009;44:521C526. doi: 10.1038/bmt.2009.263. [PubMed] [CrossRef] [Google Scholar] 207. Ljungman P, Ward KN, Crooks BN, et al. Respiratory virus infections after stem cell transplantation: a?prospective research through the Infectious Diseases Operating Party of the European Group for Blood and Marrow Transplantation. Bone tissue Marrow Transplant. 2001;28:479C484. doi: 10.1038/sj.bmt.1703139. [PubMed] [CrossRef] [Google Scholar] 208. Loftus MJ, Yong MK, Wilson S, Peleg AY. Fatal disseminated visceral varicella zoster pathogen infection within a renal transplant recipient. Transpl Infect Dis. 2019;21:e13062. doi: 10.1111/tid.13062. [PubMed] [CrossRef] [Google Scholar] 209. Lopez-Gigosos RM, Segura M, Mariscal-Lopez E, Gutierrez-Bedmar M, Mariscal A. Prevalence of Chronic Diseases among International Travelers Seeking Pretravel Medical Assistance in 2018 at Malaga, Spain. Am J Trop Med Hyg. 2020;102:684C688. doi: 10.4269/ajtmh.19-0702. [PMC free of charge article] [PubMed] [CrossRef] [Google Scholar] 210. Lopez A, Mariette X, Bachelez H, et al. Vaccination recommendations for the adult immunosuppressed affected individual: A organized review and extensive field synopsis. J Autoimmun. 2017;80:10C27. doi: 10.1016/j.jaut.2017.03.011. [PubMed] [CrossRef] [Google Scholar] 211. Macartney K, Heywood A, McIntyre P. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Cochrane Database Syst Rev. 2014 doi: 10.1002/14651858.CD001833.pub3. [PMC free content] [PubMed] [CrossRef] [Google Scholar] 212. MacIntyre CR, Shaw PJ, Mackie FE, et al. Long-term follow-up of persistence of immunity following quadrivalent Human being Papillomavirus (HPV) vaccine in immunocompromised children. Vaccine. 2019;37:5630C5636. doi: 10.1016/j.vaccine.2019.07.072. [PubMed] [CrossRef] [Google Scholar] 213. Mackall C, Fry T, Gress R, et al. History to hematopoietic cell transplantation, including post transplant immune system recovery. Bone tissue Marrow Transplant. 2009;44:457C462. doi: 10.1038/bmt.2009.255. [PubMed] [CrossRef] [Google Scholar] 214. Mackall CL, Fleisher TA, Brown MR, et al. Distinctions between CD4+ and CD8+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Bloodstream. 1997;89:3700C3707. doi: 10.1182/bloodstream.V89.10.3700. [PubMed] [CrossRef] [Google Scholar] 215. Mackay HJ, Mcgee J, Villa D, et al. Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on energetic systemic treatment. J Clin Virol. 2011;50:212C216. doi: 10.1016/j.jcv.2010.11.013. [PubMed] [CrossRef] [Google Scholar] 216. Macneil JR, Rubin LG, Patton M, et al. Tips for Usage of Meningococcal Conjugate Vaccines in HIV-Infected PersonsAdvisory Committee on Immunization Practices, 2016. Mmwr Morb Mortal Wkly Rep. 2016;65:1189C1194. doi: 10.15585/mmwr.mm6543a3. [PubMed] [CrossRef] [Google Scholar] 217. Madenci AL, Armstrong LB, Kwon NK, et al. Risk and Incidence factors for sepsis after childhood splenectomy. J Pediatr Surg. 2019;54:1445C1448. doi: 10.1016/j.jpedsurg.2018.06.024. [PubMed] [CrossRef] [Google Scholar] 218. Madhi SA, Klugman KP. A job for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med. 2004;10:811C813. doi: 10.1038/nm1077. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 219. Mahler MB, Taur Y, Jean R, et al. Safety and immunogenicity of the tetravalent protein-conjugated meningococcal vaccine (MCV4) in recipients of related and unrelated allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2012;18:145C149. doi: 10.1016/j.bbmt.2011.07.027. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 220. Manistarski M, Levin D, Dvir R, et al. Lessons From an Outbreak of Varicella Infection in Pediatric Hemato-oncology Patients. Pediatr Infect Dis J. 2018;37:649C653. doi: 10.1097/INF.0000000000001920. [PubMed] [CrossRef] [Google Scholar] 221. Mannick JB, Del Giudice G, Lattanzi M, et al. mTOR inhibition improves immune function purchase LY2109761 in older people. Sci Transl Med. 2014;6:268ra179. doi: 10.1126/scitranslmed.3009892. [PubMed] [CrossRef] [Google Scholar] 222. Manuel O, Kumar D, Vocalist LG, et al. Occurrence and clinical characteristics of herpes zoster after lung transplantation. J Heart Lung Transplant : Off Publ Int Soc Heart Transplant. 2008;27:11C16. doi: 10.1016/j.healun.2007.09.028. [PubMed] [CrossRef] [Google Scholar] 223. Martino R, Porras RP, Rabella N, et al. Potential study from the incidence, clinical features, and outcome of symptomatic upper and lower respiratory system attacks by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transplant. 2005;11:781C796. doi: 10.1016/j.bbmt.2005.07.007. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 224. Martire B, Azzari C, Badolato R, et al. Vaccination in immunocompromised web host: Suggestions of Italian Main Immunodeficiency Network Centers (IPINET) Vaccine. 2018;36:3541C3554. doi: 10.1016/j.vaccine.2018.01.061. [PubMed] [CrossRef] [Google Scholar] 225. Mazzuoccolo LD, Andrada R, Pellerano G, et al. Levels of cyclosporine in breast dairy and passing into the blood circulation of the newborn of a?mvarious other with psoriasis. Int J Dermatol. 2014;53:355C356. doi: 10.1111/j.1365-4632.2012.05534.x. [PubMed] [CrossRef] [Google Scholar] 226. Mebius RE, Kraal G. Function and Framework from the spleen. Nature reviews. Immunology. 2005;5:606C616. [PubMed] [Google Scholar] 227. Meerveld-Eggink A, De Weerdt O, De Voer RM, et al. Impaired antibody response to conjugated meningococcal serogroup C vaccine in asplenic patients. Eur J Clin Microbiol Infect Dis : Off Publ Eur Soc Clin Microbiol. 2011;30:611C618. doi: 10.1007/s10096-010-1129-2. [PubMed] [CrossRef] [Google Scholar] 228. Meerveld-Eggink A, De Weerdt O, Vehicle Der Velden AM, et al. Response to influenza disease vaccination during chemotherapy in individuals with breast cancer. Ann Oncol : Off J Eur Soc Med Oncol. 2011;22:2031C2035. doi: 10.1093/annonc/mdq728. [PubMed] [CrossRef] [Google Scholar] 229. Meerveld-Eggink A, De Weerdt O, Van Velzen-Blad H, et al. Response to conjugate Haemophilus and pneumococcal influenzae type b vaccines in asplenic individuals. Vaccine. 2011;29:675C680. doi: 10.1016/j.vaccine.2010.11.034. [PubMed] [CrossRef] [Google Scholar] 230. Mehta RS, Rezvani K. Immune reconstitution post allogeneic transplant and the impact of immune recovery on the chance of disease. Virulence. 2016;7:901C916. doi: 10.1080/21505594.2016.1208866. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 231. Meisel R, Kuypers L, Gruhn B, et al. Coadministration of the Hexavalent Mixture Vaccine Infanrix hexa? as well as the Pneumoccoccal Conjugate Vaccine Prevenar? Provides Early and Comprehensive Vaccination Insurance coverage in Kids after Unrelated and Related Allogeneic Hematopoietic Stem Cell Transplantation. Blood. 2007;110:164C164. doi: 10.1182/blood.V110.11.164.164. [CrossRef] [Google Scholar] 232. Meisel R, Toschke AM, Heiligensetzer C, et al. Increased risk for intrusive pneumococcal illnesses in kids with acute lymphoblastic leukaemia. Br J Haematol. 2007;137:457C460. doi: 10.1111/j.1365-2141.2007.06601.x. [PubMed] [CrossRef] [Google Scholar] 233. Mikoluc B, Kayhty H, Bernatowska E, et al. Immune response to the 7-valent pneumococcal conjugate vaccine in 30 asplenic kids. Eur J Clin Microbiol Infect Dis : Off Publ Eur Soc Clin Microbiol. 2008;27:923C928. doi: 10.1007/s10096-008-0523-5. [PubMed] [CrossRef] [Google Scholar] 234. Mikoluc B, Motkowski R, Kayhty H, et al. Antibody response to Haemophilus influenzae type-b conjugate vaccine in kids and adults with congenital asplenia or after going through splenectomy. Eur J Clin Microbiol Infect Dis : Off Publ Eur Soc Clin Microbiol. 2012;31:805C809. doi: 10.1007/s10096-011-1378-8. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 235. Mikulska M, Cesaro S, de Lavallade H, et al. Vaccination of individuals with haematological malignancies who didn’t have transplantations: suggestions from your 2017 European Conference on Infections in Leukaemia (ECIL 7) Lancet Infect Dis. 2019;19:e188Ce199. doi: 10.1016/S1473-3099(18)30601-7. [PubMed] [CrossRef] [Google Scholar] 236. Mina MJ, Klugman KP. The function of influenza in the severe nature and transmitting of respiratory system bacterial disease. Lancet Respir Med. 2014;2:750C763. doi: 10.1016/S2213-2600(14)70131-6. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 237. Miyairi I, Funaki T, Saitoh A. Immunization procedures in solid body organ transplant recipients. Vaccine. 2016;34:1958C1964. doi: 10.1016/j.vaccine.2016.03.001. [PubMed] [CrossRef] [Google Scholar] 238. Molica S. Attacks in chronic lymphocytic leukemia: risk factors, and impact on survival, and treatment. Leuk Lymphoma. 1994;13:203C214. doi: 10.3109/10428199409056283. [PubMed] [CrossRef] [Google Scholar] 239. Molrine DC, Guinan EC, Antin JH, et al. Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone tissue marrow transplantation. Bloodstream. 1996;87:3012C3018. doi: 10.1182/bloodstream.V87.7.3012.bloodjournal8773012. [PubMed] [CrossRef] [Google Scholar] 240. Moore SM, Hanlon CA. Rabies-specific antibodies: measuring surrogates of protection against a?fatal disease. PLoS Negl Trop Dis. 2010;4:e595. doi: 10.1371/journal.pntd.0000595. [PMC free content] [PubMed] [CrossRef] [Google Scholar] 241. Morrison VA. Infectious problems of chronic lymphocytic leukaemia: pathogenesis, spectral range of infection, preventive approaches. Best practice & research. Baillieres Clin Haematol. 2010;23:145C153. doi: 10.1016/j.beha.2009.12.004. [PubMed] [CrossRef] [Google Scholar] 242. Mulder SF, Jacobs JF, Nordkamp OMA, et al. Tumor individuals treated with sorafenib or sunitinib have sufficient antibody and cellular immune responses to warrant influenza vaccination. Clin Tumor Res. 2011;17:4541C4549. doi: 10.1158/1078-0432.CCR-11-0253. [PubMed] [CrossRef] [Google Scholar] 243. Mulley WR, Dendle C, Ling JEH, et al. Will vaccination in solid-organ transplant recipients bring about adverse immunologic sequelae? A systematic review and meta-analysis. J Heart Lung Transplant : Off Publ Int Soc Center Transplant. 2018;37:844C852. doi: 10.1016/j.healun.2018.03.001. [PubMed] [CrossRef] [Google Scholar] 244. Musto P, Carotenuto M. Vaccination against influenza in multiple myeloma. Br J Haematol. 1997;97:505C506. [PubMed] [Google Scholar] 245. Na R, Grulich AE, Meagher NS, et al. Evaluation of de novo cancers incidence in Australian liver, lung and center transplant recipients. Am J Transplant. 2013;13:174C183. doi: 10.1111/j.1600-6143.2012.04302.x. [PubMed] [CrossRef] [Google Scholar] 246. Niehues T, Bogdan C, Hecht J, et al. Impfen bei Immundefizienz: Anwendungshinweise zu den von der St?ndigen Impfkommission empfohlenen Impfungen. (I) Grundlagenpapier. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017;60:674C684. doi: 10.1007/s00103-017-2555-4. [PubMed] [CrossRef] [Google Scholar] 247. Nishio M, Fujimoto K, Yamamoto S, et al. Hypogammaglobulinemia using a?selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non-Hodgkin lymphoma. Eur J Haematol. 2006;77:226C232. doi: 10.1111/j.1600-0609.2006.00693.x. [PubMed] [CrossRef] [Google Scholar] 248. Nived P, Jorgensen CS, Settergren B. Vaccination status and immune response to 13-valent pneumococcal conjugate vaccine in asplenic people. Vaccine. 2015;33:1688C1694. doi: 10.1016/j.vaccine.2015.02.026. [PubMed] [CrossRef] [Google Scholar] 249. Nord?con T, Husebekk A, Aaberge We, et al. Humoral immunity to viral and bacterial antigens in lymphoma individuals 4C10 years after high-dose therapy with ABMT. Serological replies to revaccinations regarding to EBMT suggestions. 2001. [PubMed] [Google Scholar] 250. Offidani M, Corvatta L, Olivieri A, et al. A Predictive Style of Varicella-Zoster Virus Illness after Autologous Peripheral Blood Progenitor Cell Transplantation. Clin Infect Dis. 2001;32:1414C1422. doi: 10.1086/320157. [PubMed] [CrossRef] [Google Scholar] 251. Ojeda-Uribe M, Gilliot C, Jung G, et al. Administration of rituximab during the initial trimester of being pregnant without implications for the newborn. J Perinatol. 2006;26:252C255. doi: 10.1038/sj.jp.7211481. [PubMed] [CrossRef] [Google Scholar] 252. Ojha RP, Jackson Become, Tota JE, et al. Younger age distribution of cervical malignancy incidence among survivors of pediatric and youthful adult malignancies. Gynecol Oncol. 2014;134:309C313. doi: 10.1016/j.ygyno.2014.05.011. [PubMed] [CrossRef] [Google Scholar] 253. Ojha RP, Tota JE, Offutt-Powell TN, et al. Human papillomavirus-associated subsequent malignancies among long-term survivors of pediatric and youthful adult malignancies. Plos One. 2013;8:e70349. doi: 10.1371/journal.pone.0070349. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 254. Olarte L, Lin PL, Barson WJ, et al. Invasive pneumococcal attacks in children pursuing transplantation in the pneumococcal conjugate vaccine era. Transpl Infect Dis. 2017 doi: 10.1111/tid.12630. [PubMed] [CrossRef] [Google Scholar] 255. Oliveira LG, Sass N, Sato JL, et al. Pregnancy after renal transplantationa five-yr single-center experience. Clin Transplant. 2007;21:301C304. doi: 10.1111/j.1399-0012.2006.00627.x. [PubMed] [CrossRef] [Google Scholar] 256. Organtransplantation DS. Jahresbericht Organspende und Transplantation in Deutschland 2018. 2019. [Google Scholar] 257. Orthopoulos GV, Theodoridou MC, Ladis VA, et al. The result of 23-valent pneumococcal polysaccharide vaccine on immunological priming induced by 7-valent conjugate vaccine in asplenic topics with beta-thalassemia. Vaccine. 2009;27:350C354. doi: 10.1016/j.vaccine.2008.10.070. [PubMed] [CrossRef] [Google Scholar] 258. Pandit A, Leblebjian H, Hammond SP, et al. Protection of live-attenuated measles-mumps-rubella and herpes zoster vaccination in multiple myeloma patients on maintenance lenalidomide or bortezomib after autologous hematopoietic cell transplantation. Bone Marrow Transplant. 2018;53:942C945. doi: 10.1038/s41409-018-0112-x. [PubMed] [CrossRef] [Google Scholar] 259. Papadatou I, Orthopoulos G, Theodoridou M, et al. Long-lasting hyporesponsivenss induced by the 23-valent pneumococcal polysaccharide vaccine (PPV23) in asplenic sufferers with beta-thalassemia main. Vaccine. 2015;33:3779C3783. doi: 10.1016/j.vaccine.2015.06.100. [PubMed] [CrossRef] [Google Scholar] 260. Papadatou I, Piperi C, Alexandraki K, et al. Antigen-specific B-cell response to 13-valent pneumococcal conjugate vaccine in asplenic people with beta-thalassemia previously immunized with 23-valent pneumococcal polysaccharide vaccine. Clin Infect Dis. 2014;59:862C865. doi: 10.1093/cid/ciu409. [PubMed] [CrossRef] [Google Scholar] 261. Recreation area H, Youk J, Kim HR, et al. Infectious complications in multiple myeloma receiving autologous stem cell transplantation in the past 10?years. Int J Hematol. 2017;106:801C810. doi: 10.1007/s12185-017-2313-2. [PubMed] [CrossRef] [Google Scholar] 262. Recreation area ST, Tune MJ, Recreation area JS, et al. Incidence and clinicopathologic behavior of uterine cervical carcinoma in renal transplant recipients. World J Surg Oncol. 2011;9:72. doi: 10.1186/1477-7819-9-72. [PMC free content] [PubMed] [CrossRef] [Google Scholar] 263. Parkkali T, Kayhty H, Ruutu T, et al. An evaluation of early and past due vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT. Bone tissue Marrow Transplant. 1996;18:961C967. [PubMed] [Google Scholar] 264. Pasiarski M, Rolinski J, Grywalska E, et al. Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patientspreliminary survey. Plos One. 2014;9:e114966. doi: 10.1371/journal.pone.0114966. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 265. Patel HS, Metallic AR, Levine T, et al. Individual papillomavirus anal and infection dysplasia in renal transplant recipients. Br J Surg. 2010;97:1716C1721. doi: 10.1002/bjs.7218. [PubMed] [CrossRef] [Google Scholar] 266. Patel SR, Bate J, Borrow R, et al. Serotype-specific pneumococcal antibody concentrations in kids treated for acute leukaemia. Arch Dis Child. 2012;97:46C48. doi: 10.1136/adc.2009.176271. [PubMed] [CrossRef] [Google Scholar] 267. Patel SR, Ortin M, Cohen BJ, et al. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. Clin Infect Dis. 2007;44:625C634. doi: 10.1086/511641. [PubMed] [CrossRef] [Google Scholar] 268. Paulides M, Stohr W, Laws and regulations HJ, et al. Antibody amounts against tetanus and diphtheria after polychemotherapy for youth sarcoma: a?statement from the Past due Effects Surveillance System. Vaccine. 2011;29:1565C1568. doi: 10.1016/j.vaccine.2010.12.084. [PubMed] [CrossRef] [Google Scholar] 269. Perez-Romero P, Aydillo TA, Perez-Ordonez A, et al. Decreased occurrence of pneumonia in influenza-vaccinated solid body organ transplant recipients with influenza disease. Clin Microbiol Infect. 2012;18:E533CE540. doi: 10.1111/1469-0691.12044. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 270. Perez-Romero P, Bulnes-Ramos A, Torre-Cisneros J, et al. Influenza vaccination through the first 6?months after solid organ transplantation is efficacious and safe and sound. Clin Microbiol Infect. 2015;21(1040):e1011C1048. [PubMed] [Google Scholar] 271. Pergam SA, Forsberg CW, Boeckh MJ, et al. Herpes zoster occurrence inside a?multicenter cohort of good organ transplant recipients. Transpl Infect Dis. 2011;13:15C23. doi: 10.1111/j.1399-3062.2010.00547.x. [PMC free content] [PubMed] [CrossRef] [Google Scholar] 272. Pergam SA, Limaye AP, Practice ASTIDCO. Varicella zoster pathogen in solid body organ transplantation. Am J Transplant. 2013;13(4):138C146. doi: 10.1111/ajt.12107. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 273. Perkins JL, Chen Y, Harris A, et al. Infections among long-term survivors of years as a child and adolescent tumor: a?record from the Childhood Cancer Survivor Study. Malignancy. 2014;120:2514C2521. doi: 10.1002/cncr.28763. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 274. Petry KU, Scheffel D, Bode U, et al. Cellular immunodeficiency enhances the development of human papillomavirus-associated cervical lesions. Int J Malignancy. 1994;57:836C840. doi: 10.1002/ijc.2910570612. [PubMed] [CrossRef] [Google Scholar] 275. Pham-Huy A, Sadarangani M, Huang V, et al. From mother to baby: antenatal contact with monoclonal antibody biologics. Expert Rev Clin Immunol. 2019;15:221C229. doi: 10.1080/1744666X.2019.1561282. [PubMed] [CrossRef] [Google Scholar] 276. Pi?ana JL, Montesinos P, Martino R, et al. Occurrence, risk elements, and end result of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients. Ann Hematol. 2014;93:299C307. doi: 10.1007/s00277-013-1872-4. [PubMed] [CrossRef] [Google Scholar] 277. Piselli P, Busnach G, Fratino L, et al. De novo malignancies after body organ transplantation: concentrate on viral attacks. CMM. 2013;13:1217C1227. doi: 10.2174/15665240113139990041. [PubMed] [CrossRef] [Google Scholar] 278. Pittet LF, Verolet CM, Mclin VA, et al. Multimodal basic safety assessment of measles-mumps-rubella vaccination after pediatric liver transplantation. Am J Transplant. 2019;19:844C854. doi: 10.1111/ajt.15101. [PubMed] [CrossRef] [Google Scholar] 279. Posfay-Barbe KM, Pittet LF, Sottas C, et al. Varicella-zoster immunization in pediatric liver organ transplant recipients: secure and immunogenic. Am J Transplant. 2012;12:2974C2985. doi: 10.1111/j.1600-6143.2012.04273.x. [PubMed] [CrossRef] [Google Scholar] 280. Prelog M, Schonlaub J, Jeller V, et al. Reduced varicella-zoster-virus (VZV)-particular lymphocytes and IgG antibody avidity in solid organ transplant recipients. Vaccine. 2013;31:2420C2426. doi: 10.1016/j.vaccine.2013.03.058. [PubMed] [CrossRef] [Google Scholar] 281. Public Health Agency of Canada (2018) Bloodstream Products, Individual Immunoglobulin and Timing of Immunization: Canadian Immunization Instruction. https://www.canada.ca/en/public-health/services/canadian-immunization-guide.html. Zugegriffen: 15. M?rz 2020 282. Public Health England . Immunisation against infectious disease. In: Ramsay M, editor. Meningococcal: the green publication. London: Public Health Britain; 2013. p. 24. [Google Scholar] 283. Public Wellness England . Immunisation against infectious disease. In: Ramsay M, editor. Rabies: the green publication. London: Public Health England; 2012. pp. 1C14. [Google Scholar] 284. Puyn L. Immunogenit?t und Vertr?glichkeit des hexavalenten Kombinationsimpfstoffs Infanrix hexaTM und des 7-valenten Pneumokokkenkonjugatimpfstoffs PrevenarTM bei Kindern nach allogener h?matopoetischer Stammzelltransplantation. Dsseldorf: Klinik fr Kinder-Onkologie, -H?matologie und Klinische Immunologie der Heinrich-Heine-Universit?t; 2016. p. 99. [Google Scholar] 285. Ram S, Lewis LA, Rice PA. Attacks of individuals with go with deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev. 2010;23:740C780. doi: 10.1128/CMR.00048-09. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 286. Ravandi F, Obrien S. Defense defects in individuals with persistent lymphocytic leukemia. Malignancy Immunol Immunother. 2006;55:197C209. doi: 10.1007/s00262-005-0015-8. [PubMed] [CrossRef] [Google Scholar] 287. Reed D, Dark brown G, Merrick R, et al. A Mumps Epidemic on St. George Island, Alaska. JAMA. 1967;199:967C971. doi: 10.1001/jama.1967.03120130053007. [PubMed] [CrossRef] [Google Scholar] 288. Reich G, Mapara MY, Reichardt P, et al. Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and sufferers with solid tumors. Bone tissue Marrow Transplant. 2001;27:525C529. doi: 10.1038/sj.bmt.1702822. [PubMed] [CrossRef] [Google Scholar] 289. Reynoso EE, Shepherd FA, Messner HA, et al. Acute leukemia during being pregnant: the Toronto Leukemia Study Group encounter with long-term follow-up of children revealed in utero to chemotherapeutic realtors. J Clin Oncol. 1987;5:1098C1106. doi: 10.1200/JCO.1987.5.7.1098. [PubMed] [CrossRef] [Google Scholar] 290. Grain TW, Rubinson L, Uyeki TM, et al. Vital illness from 2009 pandemic influenza A disease and bacterial coinfection in the United States. Crit Care Med. 2012;40:1487C1498. doi: 10.1097/CCM.0b013e3182416f23. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 291. Rieger CT, Liss B, Mellinghoff S, et al. Anti-infective vaccination strategies in sufferers with hematologic malignancies or solid tumors-Guideline from the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) Ann Oncol : Off J Eur Soc Med Oncol. 2018;29:1354C1365. doi: 10.1093/annonc/mdy117. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 292. Ritzwoller DP, Bridges CB, S Shetterly, et al. Efficiency from the 2003C2004 Influenza Vaccine Among Kids six months to 8 Years of Age, With 1 vs 2 Doses. Pediatrics. 2005;116:153C159. doi: 10.1542/peds.2005-0049. [PubMed] [CrossRef] [Google Scholar] 293. Rivera L, Pena LM, Stainier I, et al. Horizontal transmission of a?human rotavirus vaccine straina randomized, placebo-controlled research in twins. Vaccine. 2011;29:9508C9513. doi: 10.1016/j.vaccine.2011.10.015. [PubMed] [CrossRef] [Google Scholar] 294. Robin C, Beckerich F, Cordonnier C. Immunization in tumor individuals: where we stand. Pharmacol Res. 2015;92:23C30. doi: 10.1016/j.phrs.2014.10.002. [PubMed] [CrossRef] [Google Scholar] 295. Rogers JE, Cumpston A, Newton M, et al. Complications and Onset of varicella zoster reactivation in the autologous hematopoietic cell transplant human population. Transpl Infect Dis. 2011;13:480C484. doi: 10.1111/j.1399-3062.2011.00655.x. [PubMed] [CrossRef] [Google Scholar] 296. Rogers ZR, Wang WC, Luo Z, et al. Biomarkers of splenic function in babies with sickle cell anemia: baseline data from the infant HUG Trial. Blood. 2011;117:2614C2617. doi: 10.1182/blood-2010-04-278747. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 297. Rosado MM, Gesualdo F, Marcellini V, et al. Preserved antibody amounts and lack of memory space B cells against pneumococcus and tetanus after splenectomy: tailoring better vaccination strategies. Eur J Immunol. 2013;43:2659C2670. doi: 10.1002/eji.201343577. [PubMed] [CrossRef] [Google Scholar] 298. Rosdahl A, Herzog C, Frosner G, et al. A supplementary priming dosage of hepatitis A vaccine to adult sufferers with rheumatoid drug and arthritis induced immunosuppressionA prospective, open-label, multi-center research. Travel Med Infect Dis. 2018;21:43C50. doi: 10.1016/j.tmaid.2017.12.004. [PubMed] [CrossRef] [Google Scholar] 299. Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA scientific practice guide for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58:309C318. doi: 10.1093/cid/cit816. [PubMed] [CrossRef] [Google Scholar] 300. SAGE (2017) Proposed revision of the policy on rabies vaccines and rabies immunoglobulins. Prepared by the SAGE Working Group on Rabies vaccines and immunoglobulins and the World Health Business (WHO) Secretariat 301. Schiff GM. Titered Plenty of Defense Globulin (Ig): Efficiency in preventing Rubella. JAMA Pediatr. 1969;118:322C327. [PubMed] [Google Scholar] 302. Schrauder A, Henke-Gendo C, Seidemann K, et al. Varicella vaccination in a?child with acute lymphoblastic leukaemia. Lancet. 2007;369:1232. doi: 10.1016/S0140-6736(07)60567-4. [PubMed] [CrossRef] [Google Scholar] 303. Schuchter LM, Wingard JR, Piantadosi S, et al. Herpes zoster contamination after autologous bone tissue marrow transplantation. Bloodstream. 1989;74:1424C1427. doi: 10.1182/bloodstream.V74.4.1424.1424. [PubMed] [CrossRef] [Google Scholar] 304. Schwartz BS, Rosen J, Han PV, et al. Immunocompromised travelers: demographic features, travel locations, and Pretravel health care from your U.S. Global TravEpinet consortium. Am J Trop Med Hyg. 2015;93:1110C1116. doi: 10.4269/ajtmh.15-0185. [PMC free content] [PubMed] [CrossRef] [Google Scholar] 305. Schwartz PE, Sterioff S, Mucha P, et al. Postsplenectomy sepsis and mortality in adults. JAMA. 1982;248:2279C2283. doi: 10.1001/jama.1982.03330180039029. [PubMed] [CrossRef] [Google Scholar] 306. M Scully, Starke R, Lee R, et al. Effective management of pregnancy in women having a?history of thrombotic thrombocytopaenic purpura. Blood Coagulation Fibrinolysis : Int J Haemostasis Thromb. 2006;17:459C463. doi: 10.1097/01.mbc.0000240918.65306.20. [PubMed] [CrossRef] [Google Scholar] 307. Serio B, Pezzullo L, Giudice V, et al. OPSI risk in hematological sufferers. Transl Med UniSa. 2013;6:2C10. [PMC free of charge content] [PubMed] [Google Scholar] 308. Serrano B, Bayas JM, Bruni L, et al. Solid organ transplantation and response to vaccination. Vaccine. 2007;25:7331C7338. doi: 10.1016/j.vaccine.2007.08.031. [PubMed] [CrossRef] [Google Scholar] 309. Sharma-Chawla N, Sender V, Kershaw O, et al. Influenza A Disease Illness Predisposes Hosts to Secondary An infection with Different Streptococcus pneumoniae Serotypes with Very similar Final result but Serotype-Specific Manifestation. Infect Immun. 2016;84:3445C3457. doi: 10.1128/IAI.00422-16. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 310. Shatz DV. Vaccination considerations in the asplenic individual. Expert Rev Vaccines. 2005;4:27C34. doi: 10.1586/14760584.4.1.27. [PubMed] [CrossRef] [Google Scholar] 311. Shinjoh M, Hoshino K, Takahashi T, et al. Up to date data on secure and efficient immunizations with live-attenuated vaccines for kids after living donor liver organ transplantation. Vaccine. 2015;33:701C707. doi: 10.1016/j.vaccine.2014.11.052. [PubMed] [CrossRef] [Google Scholar] 312. Shinjoh M, Miyairi I, Hoshino K, et al. Effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation. Vaccine. 2008;26:6859C6863. doi: 10.1016/j.vaccine.2008.09.076. [PubMed] [CrossRef] [Google Scholar] 313. Siber Gr WB, Halsey NRR, Almeido-Hill J, Sc G, Thompson C, Santosham M. Disturbance of immune system globulin with measles and rubella immunization. J Pediatr. 1993;122:204C211. doi: 10.1016/S0022-3476(06)80114-9. [PubMed] [CrossRef] [Google Scholar] 314. Sicre De Fontbrune F, Arnaud C, Cheminant M, et al. Immunogenicity and Safety of Yellow Fever Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients After Drawback of Immunosuppressive Therapy. J INFECT DIS. 2018;217:494C497. doi: 10.1093/infdis/jix564. [PubMed] [CrossRef] [Google Scholar] 315. Sinisalo M, Aittoniemi J, Oivanen P, et al. Response to vaccination against various kinds of antigens in individuals with chronic lymphocytic leukaemia. Br J Haematol. 2001;114:107C110. doi: 10.1046/j.1365-2141.2001.02882.x. [PubMed] [CrossRef] [Google Scholar] 316. Sinwar PD. Overpowering post splenectomy infection syndromereview study. Int J Surg. 2014;12:1314C1316. doi: 10.1016/j.ijsu.2014.11.005. [PubMed] [CrossRef] [Google Scholar] 317. Small TN, Avigan D, Dupont B, et al. Immune reconstitution pursuing T-cell depleted bone tissue marrow transplantation: aftereffect of age and posttransplant graft rejection prophylaxis. Biology of blood and marrow transplantation : journal of the American Society for Bloodstream and Marrow. Transplantation. 1997;3:65C75. [PubMed] [Google Scholar] 318. Smedegaard LM, Poulsen A, Kristensen IA, et al. Varicella Vaccination of Children With Leukemia Without Interruption of Maintenance Therapy: A Danish Experience. Pediatr Infect Dis J. 2016;35:e348Ce352. doi: 10.1097/INF.0000000000001279. [PubMed] [CrossRef] [Google Scholar] 319. Smets F, Bourgois A, Vermylen C, et al. Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic kids previously vaccinated with polysaccharide vaccine. Vaccine. 2007;25:5278C5282. doi: 10.1016/j.vaccine.2007.05.014. [PubMed] [CrossRef] [Google Scholar] 320. Smith LH, Dalrymple JL, Leiserowitz GS, et al. Obstetrical deliveries connected with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol. 2001;184:1504C1512. doi: 10.1067/mob.2001.114867. [PubMed] [CrossRef] [Google Scholar] 321. Smith S, Schiffman G, Karayalcin G, et al. Immunodeficiency in long-term survivors of severe lymphoblastic leukemia treated with Berlin-Frankfurt-Munster therapy. J Pediatr. 1995;127:68C75. doi: 10.1016/S0022-3476(95)70259-8. [PubMed] [CrossRef] [Google Scholar] 322. Spoulou V, Tzanakaki G, Lekka S, et al. Normal and vaccine-induced immunity to Neisseria meningitidis serogroup C in asplenic patients with beta-thalassemia. Vaccine. 2011;29:4435C4438. doi: 10.1016/j.vaccine.2011.03.080. [PubMed] [CrossRef] [Google Scholar] 323. Stadtmauer EA, Sullivan Kilometres, Marty FM, et al. A stage 1/2 study of the adjuvanted varicella-zoster pathogen subunit vaccine in autologous hematopoietic cell transplant recipients. Blood. 2014;124:2921C2929. doi: 10.1182/blood-2014-04-573048. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 324. Staehelin C, Hirzel C, Hauser C, et al. Vaccinations for immunocompromised hostsfocussing on sufferers after a?hematological stem organ or cell transplantation, with HIV or with anatomical or functional asplenia]. Therapeutische Umschau. Ther Umsch. 2016;73:281C289. doi: 10.1024/0040-5930/a000793. [PubMed] [CrossRef] [Google Scholar] 325. Stammzelltransplantationen DRF. Jahresbericht 2018 Deutsches Register fr Stammzelltransplantationen. 2018. [Google Scholar] 326. St?ndige Impfkommission Aktualisierung der Meningokokken-Impfempfehlung: Anwendung des Meningokokken-B-Impfstoffs bei Personen mit erh?htem Risiko fr Meningokokken-Erkrankungen. Epidemiol Bull. 2015;37:393C410. [Google Scholar] 327. St?ndige Impfkommission Empfehlungen der St?ndigen Impfkommission (STIKO) am Robert Koch-Institut. Epidemiol Bull. 2019;34:313C364. [Google Scholar] 328. St?ndige Impfkommission Mitteilung der St?ndigen Impfkommission (STIKO) am RKI C Empfehlung und wissenschaftliche Begrndung der Empfehlung zur Rotavirus-Standardimpfung von S?uglingen. Epidemiol Bull. 2013;35:349C361. [Google Scholar] 329. St?ndige Impfkommission Mitteilung der St?ndigen Impfkommission am Robert Koch-Institut (RKI) C Wissenschaftliche Begrndung fr die Aktualisierung der Pneumokokken-Impfempfehlung fr Senioren. Epid Bull. 2016;36:351C383. [Google Scholar] 330. St?ndige Impfkommission Stellungnahme der STIKO: Fachliche Anwendungshinweise zur Masern-Postexpositionsprophylaxe bei Risikopersonen. Epid Bull. 2017 doi: 10.17886/EpiBull-2017-002.1. [CrossRef] [Google Scholar] 331. St?ndige Impfkommission Wissenschaftliche Begrndung die Aktualisierung der Empfehlungen zur Indikationsimpfung gegen Pneumokokken fr Risikogruppen. Epidemiol Bull. 2016;37:385C406. [Google Scholar] 332. St?ndige Impfkommission Wissenschaftliche Begrndung fr die ?nderung der Empfehlung zur Impfung gegen Hepatitis B. Epid Bull. 2013;36/37:371C381. [Google Scholar] 333. St?ndige Impfkommission Wissenschaftliche Begrndung fr die ge?nderte Empfehlung zur Anwendung von Influenza-Impfstoffen bei Kindern und Jugendlichen im Alter von 2C17?Jahren. Epid Bull. 2017;35:384C385. [Google Scholar] 334. St?ndige Impfkommission Wissenschaftliche Begrndung zur Empfehlung einer Impfung mit dem Herpes zoster-subunit-Totimpfstoff. Epidemiol Bull. 2018;50:541C567. [Google Scholar] 335. Stanford E, Printing F, Falconer M, et al. Defense response to pneumococcal conjugate vaccination in asplenic people. Hum Vaccin. 2009;5:85C91. doi: 10.4161/hv.5.2.6557. [PubMed] [CrossRef] [Google Scholar] 336. Stark K, Gunther M, Neuhaus R, et al. Security and Immunogenicity of hepatitis A vaccine in liver and renal transplant recipients. J INFECT DIS. 1999;180:2014C2017. doi: 10.1086/315125. [PubMed] [CrossRef] [Google Scholar] 337. Steininger PA, Bobinger T, Dietrich W, et al. Two Situations of Serious Tick-Borne Encephalitis in Rituximab-Treated Sufferers in Germany: Implications for Analysis and Prevention. Open Discussion board Infect Dis. 2017;4:ofx204. doi: 10.1093/ofid/ofx204. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 338. Sternfeld T, Spori-Byrtus V, Riediger C, et al. Acute measles infection triggering an bout of liver organ transplant rejection. Int J Infect Dis. 2010;14:e528C530. doi: 10.1016/j.ijid.2009.06.013. [PubMed] [CrossRef] [Google Scholar] 339. Stoehr GA, Rose MA, Eber SW, et al. Immunogenicity of sequential pneumococcal vaccination in topics splenectomised for hereditary spherocytosis. Br J Haematol. 2006;132:788C790. doi: 10.1111/j.1365-2141.2005.05918.x. [PubMed] [CrossRef] [Google Scholar] 340. Storek J, Witherspoon RP, Storb R. T cell reconstitution after bone tissue marrow transplantation into adult patients does not resemble T cell development in early existence. Bone tissue Marrow Transplant. 1995;16:413C425. [PubMed] [Google Scholar] 341. Struijk GH, Minnee RC, Koch SD, et al. Maintenance immunosuppressive therapy with everolimus preserves humoral immune system responses. Kidney Int. 2010;78:934C940. doi: 10.1038/ki.2010.269. [PubMed] [CrossRef] [Google Scholar] 342. Su SH, Martel-Laferriere V, Labbe AC, et al. High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2011;17:1012C1017. doi: 10.1016/j.bbmt.2010.10.025. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 343. Sunlight C, Gao J, Couzens L, et al. Seasonal Influenza Vaccination in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib. JAMA Oncol. 2016;2:1656C1657. doi: 10.1001/jamaoncol.2016.2437. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 344. Tadmor T, Welslau M, Hus I. A review of the infection prophylaxis and pathogenesis recommendations in sufferers with chronic lymphocytic leukemia. Expert Rev Hematol. 2018;11:57C70. doi: 10.1080/17474086.2018.1407645. [PubMed] [CrossRef] [Google Scholar] 345. Takata T, Suzumiya J, Ishikawa T, et al. Attenuated antibody response for the principal antigen but not for the recall antigen of influenza vaccination in patients with non-Hodgkin B-cell lymphoma after the administration of rituximab-CHOP. J Clin Exp Hematop. 2009;49:9C13. doi: 10.3960/jslrt.49.9. [PubMed] [CrossRef] [Google Scholar] 346. Tangye SG, Great KL. Individual IgM+Compact disc27+ B cells: storage B cells or memory B cells? J Immunol. 2007;179:13C19. doi: 10.4049/jimmunol.179.1.13. [PubMed] [CrossRef] [Google Scholar] 347. Theilacker C, Ludewig K, Serr A, et al. Overwhelming Postsplenectomy Contamination: A Prospective Multicenter Cohort Research. Clin Infect Dis. 2016;62:871C878. doi: 10.1093/cid/civ1195. [PubMed] [CrossRef] [Google Scholar] 348. Thomsen RW, Schoonen WM, Farkas DK, et al. Risk for medical center contact with infections in sufferers with splenectomy: a?population-based cohort study. Ann Intern Med. 2009;151:546C555. doi: 10.7326/0003-4819-151-8-200910200-00008. [PubMed] [CrossRef] [Google Scholar] 349. Thomson KJ, Hart DP, Banerjee L, et al. The effect of low-dose aciclovir on reactivation of varicella zoster computer virus after allogeneic haemopoietic stem cell transplantation. Bone Marrow Transplant. 2005;35:1065C1069. doi: 10.1038/sj.bmt.1704959. [PubMed] [CrossRef] [Google Scholar] 350. Tomblyn M, Chiller T, Einsele H, et al. Guidelines for stopping infectious problems among hematopoietic cell transplantation recipients: a?global perspective. Biol Bloodstream Marrow Transplant. 2009;15:1143C1238. doi: 10.1016/j.bbmt.2009.06.019. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 351. Tran L, Hebert D, Dipchand A, et al. Invasive pneumococcal disease in pediatric organ transplant recipients: a?high-risk population. Pediatr Transplantation. 2005;9:183C186. doi: 10.1111/j.1399-3046.2005.00275.x. [PubMed] [CrossRef] [Google Scholar] 352. Trubiano JA, Johnson D, Sohail A, Torresi J. Travel vaccination recommendations and endemic an infection dangers in solid body organ transplantation recipients. J Travel Med. 2016 doi: 10.1093/jtm/taw058. [PubMed] [CrossRef] [Google Scholar] 353. Tsolia M, Gershon AA, Steinberg SP, et al. Live attenuated varicella vaccine: evidence that the disease is attenuated and the importance of skin lesions in transmitting of varicella-zoster trojan. National Institute of Infectious and Allergy Diseases Varicella Vaccine Collaborative Study Group. J Pediatr. 1990;116:184C189. doi: 10.1016/S0022-3476(05)82872-0. [PubMed] [CrossRef] [Google Scholar] 354. Udink Ten Cate FE, Ten Hove CH, Nix WM, et al. Transient neonatal myelosuppression after fetal contact with maternal chemotherapy. Case survey and overview of the books. Neonatology. 2009;95:80C85. doi: 10.1159/000151759. [PubMed] [CrossRef] [Google Scholar] 355. Ullmann AJ, Schmidt-Hieber M, Bertz H, et al. Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis technique recommendations 2016. Ann. Hematol. 2016;95:1435C1455. doi: 10.1007/s00277-016-2711-1. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 356. Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical practice guidelines by the infectious diseases society of america: 2018 update on analysis, treatment, Chemoprophylaxis, and institutional outbreak administration of seasonal Influenzaa. Clin Infect Dis. 2018;68:e1Ce47. doi: 10.1093/cid/ciy866. [PMC free of charge article] [PubMed] [CrossRef] [Google Scholar] 357. Van De Wetering Vossen Jansen MDMTMH, et al. Varicella vaccination in pediatric oncology patients without interruption of chemotherapy. J Clin Virol. 2016;75:47C52. doi: 10.1016/j.jcv.2016.01.004. [PubMed] [CrossRef] [Google Scholar] 358. Van Der Kolk LE, Baars JW, Prins MH, et al. Rituximab treatment leads to impaired supplementary humoral immune system responsiveness. Bloodstream. 2002;100:2257C2259. doi: 10.1182/blood.V100.6.2257. [PubMed] [CrossRef] [Google Scholar] 359. Van Der Velden AM, Claessen AM, Van Velzen-Blad H, et al. Advancement of useful Haemophilus influenzae type b antibodies after vaccination. Haematologica. 2005;90:1582C1584. [PubMed] [Google Scholar] 360. Truck Der Velden AM, Claessen AM, Truck Velzen-Blad H, et al. Vaccination responses and lymphocyte subsets after autologous stem cell transplantation. Vaccine. 2007;25:8512C8517. doi: 10.1016/j.vaccine.2007.10.008. [PubMed] [CrossRef] [Google Scholar] 361. Van Tilburg CM, Sanders EA, Rovers MM, et al. Loss of antibodies and response to (re-)vaccination in children after treatment for severe lymphocytic leukemia: a?organized review. Leukemia. 2006;20:1717C1722. doi: 10.1038/sj.leu.2404326. [PubMed] [CrossRef] [Google Scholar] 362. Vance E, George S, Guinan EC, et al. Comparison of multiple immunization schedules for Haemophilus influenzae type tetanus and b-conjugate toxoid vaccines following bone tissue marrow transplantation. Bone tissue Marrow Transplant. 1998;22:735C741. doi: 10.1038/sj.bmt.1701424. [PubMed] [CrossRef] [Google Scholar] 363. Vardhana S, Cicero K, Velez MJ, et al. Approaches for Realizing and Managing Immune-Mediated Adverse Events in the treating Hodgkin Lymphoma with Checkpoint Inhibitors. The Oncol. 2019;24:86C95. doi: 10.1634/theoncologist.2018-0045. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 364. Vernacchio L, Neufeld EJ, Macdonald K, et al. Mixed timetable of 7-valent pneumococcal conjugate vaccine accompanied by 23-valent pneumococcal vaccine in kids and young adults with sickle cell disease. J Pediatr. 1998;133:275C278. doi: 10.1016/S0022-3476(98)70235-5. [PubMed] [CrossRef] [Google Scholar] 365. Vesikari T, Karvonen A, Korhonen T, et al. A randomized, double-blind study of the security, transmissibility and phenotypic and genotypic balance of cold-adapted influenza trojan vaccine. Pediatr Infect Dis J. 2006;25:590C595. doi: 10.1097/01.inf.0000220229.51531.47. [PubMed] [CrossRef] [Google Scholar] 366. Vincent P. The immunocompromised traveller. South African J Epidemiol Infect. 2008;23:22C26. doi: 10.1080/10158782.2008.11441319. [CrossRef] [Google Scholar] 367. Vink P, Torrell RJM, Sanchez Fructuoso A, et al. Immunogenicity and Security of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Pursuing Renal Transplant: A Stage 3, Randomized Clinical Trial. Clin Infect Dis. 2020;70:181C190. [PMC free of charge article] [PubMed] [Google Scholar] 368. Vinograd I, Eliakim-Raz N, Farbman L, et al. Clinical performance of seasonal influenza vaccine among adult malignancy patients. Tumor. 2013;119:4028C4035. doi: 10.1002/cncr.28351. [PubMed] [CrossRef] [Google Scholar] 369. Vu HT, Yoshida LM, Suzuki M, et al. Association between nasopharyngeal load of Streptococcus pneumoniae, viral coinfection, and confirmed pneumonia in Vietnamese kids radiologically. Pediatr Infect Dis J. 2011;30:11C18. doi: 10.1097/INF.0b013e3181f111a2. [PubMed] [CrossRef] [Google Scholar] 370. Waghorn DJ. Overpowering infection in asplenic patients: current best practice preventive actions are not becoming adopted. J Clin Pathol. 2001;54:214C218. doi: 10.1136/jcp.54.3.214. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 371. Waghorn DJ, Mayon-White RT. A study of 42 shows of overpowering post-splenectomy infection: is current guidance for asplenic individuals being adopted? J Infect. 1997;35:289C294. doi: 10.1016/S0163-4453(97)93232-1. [PubMed] [CrossRef] [Google Scholar] 372. Wagner N, Assmus F, Arendt G, et al. Impfen bei Immundefizienz: Anwendungshinweise zu den von der St?ndigen Impfkommision empfohlenen Impfungen. (IV) Impfen bei Autoimmunkrankheiten, bei anderen chronisch-entzndlichen Erkrankungen und unter immunmodulatorischer Therapie. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019;62:494C515. doi: 10.1007/s00103-019-02905-1. [PubMed] [CrossRef] [Google Scholar] 373. Wang SH, Loh PY, Lin TL, et al. Dynamic immunization for avoidance of De novo hepatitis B virus infections after adult living donor liver organ transplantation using a?hepatitis B core antigen-positive graft. Liver Transpl. 2017;23:1266C1272. doi: 10.1002/lt.24814. [PubMed] [CrossRef] [Google Scholar] 374. Weil BR, Madenci AL, Liu Q, et al. Late Infection-Related Mortality in Asplenic Survivors of Years as a child Cancer: A WRITTEN REPORT From the Years as a child Cancer Survivor Study. J Clin Oncol. 2018;36:1571C1578. doi: 10.1200/JCO.2017.76.1643. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 375. Weitberg Stomach, Weitzman SA, Watkins E, et al. Immunogenicity of hepatitis B vaccine in oncology sufferers getting chemotherapy. J Clin Oncol. 1985;3:718C722. doi: 10.1200/JCO.1985.3.5.718. [PubMed] [CrossRef] [Google Scholar] 376. Weller S, Braun MC, Tan BK, et al. Human blood IgM memory B cells are circulating splenic marginal zone B cells harboring a?prediversified immunoglobulin repertoire. Blood. 2004;104:3647C3654. doi: 10.1182/bloodstream-2004-01-0346. [PMC free of charge content] [PubMed] [CrossRef] [Google Scholar] 377. Wiedermann U, Sitte HH, Burgmann H, et al. Recommendations for vaccination of immunocompromised individuals. Wien Klin Wochenschr. 2016;128(4):337C376. doi: 10.1007/s00508-016-1033-6. [PubMed] [CrossRef] [Google Scholar] 378. Wieten RW, Goorhuis A, Jonker EFF, et al. 17D yellow fever vaccine elicits equivalent long-term immune replies in healthy people and immune-compromised individuals. J Infect. 2016;72:713C722. doi: 10.1016/j.jinf.2016.02.017. [PubMed] [CrossRef] [Google Scholar] 379. Wijn DH, Groeneveld GH, Vollaard AM, et al. Influenza vaccination in individuals with lung malignancy receiving anti-programmed death receptor 1 immunotherapy will not induce immune-related undesirable occasions. Eur J Malignancy. 2018;104:182C187. doi: 10.1016/j.ejca.2018.09.012. [PubMed] [CrossRef] [Google Scholar] 380. Wimperis JZ, Brenner MK, Prentice HG, et al. Transfer of a?functioning humoral immune system in transplantation of T-lymphocyte-depleted bone tissue marrow. Lancet. 1986;1:339C343. doi: 10.1016/S0140-6736(86)92315-9. [PubMed] [CrossRef] [Google Scholar] 381. Wong A, Marrie TJ, Garg S, et al. Elevated threat of invasive pneumococcal disease in haematological and solid-organ malignancies. Epidemiol Infect. 2010;138:1804C1810. doi: 10.1017/S0950268810000919. [PubMed] [CrossRef] [Google Scholar] 382. World health Organization (2019) Yellow Fever. https://www.who.int/news-room/fact-sheets/detail/yellow-fever. Zugegriffen: 4. 2020 April 383. World Wellness Organization WHO Professional Appointment on Rabies. World Health Organ Tech Rep Ser. 2018;3:1C195. [Google Scholar] 384. Wumkes ML, Van Der Velden AM, Los M, et al. Serum antibody response to influenza disease vaccination during chemotherapy treatment in adult individuals with solid tumours. Vaccine. 2013;31:6177C6184. doi: 10.1016/j.vaccine.2013.10.053. [PubMed] [CrossRef] [Google Scholar] 385. Wyplosz B, Burdet C, Francois H, et al. Persistence of yellowish fever vaccine-induced antibodies after solid body organ transplantation. Am J Transplant. 2013;13:2458C2461. doi: 10.1111/ajt.12338. [PubMed] [CrossRef] [Google Scholar] 386. Yax JA, Farnon EC, Engleberg CN. Successful immunization of an allogeneic bone marrow transplant receiver with live, attenuated yellowish Fever vaccine. J Travel Med. 2009;16:365C367. doi: 10.1111/j.1708-8305.2009.00336.x. [PubMed] [CrossRef] [Google Scholar] 387. Little MK, Cripps AW, Nimmo GR, truck Driel ML. Post-exposure unaggressive immunisation for stopping rubella and congenital rubella syndrome. Cochrane Database Syst Rev. 2015 doi: 10.1002/14651858.CD010586.pub2. [PubMed] [CrossRef] [Google Scholar] 388. Youssef S, Rodriguez G, Rolston KV, et al. Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: scientific characteristics of attacks and vaccine-breakthrough attacks, 1989C2005. Medication. 2007;86:69C77. doi: 10.1097/md.0b013e31803eb176. [PubMed] [CrossRef] [Google Scholar] 389. Zheng S, Easterling TR, Hays K, et al. Tacrolimus placental transfer at delivery and neonatal exposure through breast milk. Br J Clin Pharmacol. 2013;76:988C996. doi: 10.1111/bcp.12122. [PMC free content] [PubMed] [CrossRef] [Google Scholar] 390. Zignol M, Peracchi M, Tridello G, et al. Evaluation of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in kids after chemotherapy. Malignancy. 2004;101:635C641. doi: 10.1002/cncr.20384. [PubMed] [CrossRef] [Google Scholar]. G.?Kobbe, W.?Klper, T.?Lehrnbecher, R.?Meisel, A.?Simon, A.?Ullmann, M.?de Wit und F.?Zepp geben an, dass kein Interessenkonflikt besteht. Literatur 1. Acar S, Gencdal G, Kirimlioglu H, Polat KY, Cagatay AA, Akyildiz M. Varicella-Zoster Virus-Induced Hepatitis inside a Liver Transplant Recipient: AN INSTANCE Survey. Transplant Proc. 2019;51:1193C1195. doi: 10.1016/j.transproceed.2019.01.092. [PubMed] [CrossRef] [Google Scholar] 2. Company EM (2018) Summary of product characteristicsShingrix. https://www.ema.europa.eu/en/documents/product-information/shingrix-epar-product-information_en.pdf. Zugegriffen: 18. M?rz 2020 3. Ambati A, Einarsdottir S, Magalhaes I, et al. Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients. Transpl Infect Dis. 2015;17:371C379. doi: 10.1111/tid.12382. [PubMed] [CrossRef] [Google Scholar] 4. Ammann AJ, Addiego J, Wara DW, et al. Polyvalent pneumococcal-polysaccharide immunization of individuals with sickle-cell individuals and anemia with splenectomy. N Engl J Med. 1977;297:897C900. doi: 10.1056/NEJM197710272971701. [PubMed] [CrossRef] [Google Scholar] 5. Anderson EJ. Rotavirus vaccines: viral dropping and risk of transmission. Lancet Infect Dis. 2008;8:642C649. doi: 10.1016/S1473-3099(08)70231-7. [PubMed] [CrossRef] [Google Scholar] 6. Anderson H, Petrie K, Berrisford C, et al. Seroconversion after influenza vaccination in sufferers with lung cancers. Br J Cancers. 1999;80:219C220. doi: 10.1038/sj.bjc.6690342. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 7. Ando S. Performance of quadrivalent influenza vaccine based on the test-negative control research in children through the 2016C2017 period. J Infect Chemother. 2018;24:782C788. doi: 10.1016/j.jiac.2018.05.012. [PubMed] [CrossRef] [Google Scholar] 8. Antonelli NM, Dotters DJ, Katz VL, et al. Tumor in being pregnant: a?overview of the literature. Part I. Obstet Gynecol Surv. 1996;51:125C134. doi: 10.1097/00006254-199602000-00022. [PubMed] [CrossRef] [Google Scholar] 9. Arnott A, Jones P, Franklin LJ, et al. A Registry for Patients With Asplenia/Hyposplenism Reduces the chance of Attacks With Encapsulated Microorganisms. Clin Infect Dis. 2018;67:557C561. doi: 10.1093/cid/ciy141. [PubMed] [CrossRef] [Google Scholar] 10. Arslan M, Wiesner RH, Poterucha JJ, et al. Hepatitis A antibodies in liver transplant recipients: evidence for loss of immunity posttransplantation. Liver Transpl. 2000;6:191C195. doi: 10.1002/lt.500060216. [PubMed] [CrossRef] [Google Scholar] 11. Arslan M, Wiesner RH, Poterucha JJ, et al. Efficacy and Safety of hepatitis A vaccination in liver transplantation recipients. Transplantation. 2001;72:272C276. doi: 10.1097/00007890-200107270-00019. [PubMed] [CrossRef] [Google Scholar] 12. Aung AK, Trubiano JA, Spelman DW. Travel risk evaluation, tips and vaccinations in immunocompromised vacationers (HIV, solid organ transplant and haematopoeitic stem cell transplant recipients): A review. Travel Med Infect Dis. 2015;13:31C47. doi: 10.1016/j.tmaid.2014.12.007. [PubMed] [CrossRef] [Google Scholar] 13. Australian Technical Advisory Group on Immunisation (ATAGI) Australian Immunisation Handbook. In: Wellness AGDo, editor. Vaccination for particular risk groupings. Canberra: Australian Government Department of Health; 2018. [Google Scholar] 14. Avelino-Silva VI, Freire Mda S, Rocha V, et al. Persistence of Yellow Fever vaccine-induced antibodies after cable bloodstream stem cell transplant. Hum Vaccines Immunother. 2016;12:937C938. doi: 10.1080/21645515.2015.1112475. [PMC free of charge article] [PubMed] [CrossRef] [Google Scholar] 15. Avery RK. Influenza vaccines in the setting of solid-organ transplantation: are they safe? Curr Opin Infect Dis. 2012;25:464C468. doi: 10.1097/QCO.0b013e328355a79b. [PubMed] [CrossRef] [Google Scholar] 16. Avery RK, Michaels M. Revise on immunizations in solid body organ transplant recipients: what clinicians need to find out. Am J Transplant. 2008;8:9C14. doi: 10.1111/j.1600-6143.2007.02051.x. [PubMed] [CrossRef] [Google Scholar] 17. Avetisyan G, Aschan J, Hassan M, et al. Evaluation of immune system responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation. Transplantation. 2008;86:257C263. doi: 10.1097/TP.0b013e3181772a75. [PubMed] [CrossRef] [Google Scholar] 18. Azevedo LS, Lasmar EP, Contieri FL, et al. Yellowish fever vaccination in body organ transplanted sufferers: could it be safe? A multicenter study. Transpl Infect Dis. 2012;14:237C241. doi: 10.1111/j.1399-3062.2011.00686.x. [PubMed] [CrossRef] [Google Scholar] 19. Baas MC, Vehicle Donselaar KA, Florquin S, et al. Mumps: no innocent bystander in solid body organ transplantation. Am J Transplant. 2009;9:2186C2189. doi: 10.1111/j.1600-6143.2009.02732.x. [PubMed] [CrossRef] [Google Scholar] 20. Backhaus E, Berg S, Andersson R, et al. Epidemiology of intrusive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk elements. BMC Infect Dis..